<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Periodontiamedica.com &#187; Teses</title>
	<atom:link href="http://www.periodontiamedica.com.br/category/teses/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.periodontiamedica.com.br</link>
	<description></description>
	<lastBuildDate>Fri, 27 Jan 2012 11:51:34 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Bruno Rescala defende tese de doutorado na UERJ</title>
		<link>http://www.periodontiamedica.com.br/bruno-rescala-defende-tese-de-doutorado-na-uerj/</link>
		<comments>http://www.periodontiamedica.com.br/bruno-rescala-defende-tese-de-doutorado-na-uerj/#comments</comments>
		<pubDate>Sun, 25 Apr 2010 13:21:28 +0000</pubDate>
		<dc:creator>cmfigueredo</dc:creator>
				<category><![CDATA[Teses]]></category>
		<category><![CDATA[carlos marcelo Figueredo]]></category>
		<category><![CDATA[gengivite]]></category>
		<category><![CDATA[periodontia]]></category>
		<category><![CDATA[periodontite]]></category>

		<guid isPermaLink="false">http://www.periodontiamedica.com.br/?p=286</guid>
		<description><![CDATA[O agora doutor Bruno Rescala defendeu sua tese de doutorado na UERJ entitulada &#8220;Perfil imunológico e microbiológico de pacientes com periodontites crônica e agressiva&#8221;, publicada em anexo na íntegra.
O assunto é desafiador e, mais uma vez, como fez no mestrado, Bruno emplacou seu material de pesquisa em revistas Quails A internacional.
Tese Doutorado 

]]></description>
			<content:encoded><![CDATA[<p style="text-align: center;"><a href="http://www.periodontiamedica.com.br/wp-content/uploads/2010/04/DSCN6718ot22.jpg"><img class="size-thumbnail wp-image-291 aligncenter" title="DSCN6718ot(2)" src="http://www.periodontiamedica.com.br/wp-content/uploads/2010/04/DSCN6718ot22-150x150.jpg" alt="" width="150" height="150" /></a>O agora doutor Bruno Rescala defendeu sua tese de doutorado na UERJ entitulada &#8220;<strong>Perfil imunológico e microbiológico de pacientes com periodontites crônica e agressiva&#8221;, </strong>publicada em anexo na íntegra<strong>.</strong></p>
<p>O assunto é desafiador e, mais uma vez, como fez no mestrado, Bruno emplacou seu material de pesquisa em revistas Quails A internacional.</p>
<p><strong><a href="http://www.periodontiamedica.com.br/wp-content/uploads/2010/04/Tese-Doutorado-Bruno-Final.a2.doc" target="_blank">Tese Doutorado </a><br />
</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.periodontiamedica.com.br/bruno-rescala-defende-tese-de-doutorado-na-uerj/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Function of Neutrophilic Granulocytes in Periodontitis A Pathogenetic Study of a Tissue-Destructive Inflammation by Anders Gustafsson</title>
		<link>http://www.periodontiamedica.com.br/function-of-neutrophilic-granulocytes-in-periodontitis-a-pathogenetic-study-of-a-tissue-destructive-inflammation-by-anders-gustafsson/</link>
		<comments>http://www.periodontiamedica.com.br/function-of-neutrophilic-granulocytes-in-periodontitis-a-pathogenetic-study-of-a-tissue-destructive-inflammation-by-anders-gustafsson/#comments</comments>
		<pubDate>Mon, 15 Mar 2010 01:17:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Teses]]></category>

		<guid isPermaLink="false">http://www.periodontiamedica.com.br/?p=118</guid>
		<description><![CDATA[



From       the Center of Clinical Oral Siences, Department of
Periodontology        and the Department of  Medical        Laboratory Sciences
and       Technology, Division of Clinical Chemistry,
Karolinska        [...]]]></description>
			<content:encoded><![CDATA[<table border="0" cellspacing="0" cellpadding="0" width="658">
<tbody>
<tr>
<td width="624">
<p>From       the Center of Clinical Oral Siences, Department of</p>
<p>Periodontology        and the Department of <strong> </strong>Medical        Laboratory Sciences</p>
<p>and       Technology, Division of Clinical Chemistry,</p>
<p>Karolinska        Institutet, Stockholm, Sweden</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong>Function       of Neutrophilic Granulocytes in Periodontitis </strong></p>
<p><strong>A       Pathogenetic Study of a Tissue-Destructive Inflammation</strong></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p>Anders        Gustafsson</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p>Stockholm        1995</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Abstract</strong><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p>The       presence of bacteria in gingival crevices causes an inflammatory  response,       that is tissue-destructive in about 5-10% of the population. This       destructive inflammation seems to be patient associated, rather  than to be       caused by specific periopathogens -i.e., a host-specific response  to an       essentially normal bacterial colonization of the gingival sulcus.  There       are several reasons why neutrophils may be involved in tissue  destruction       in periodontitis: i) they release active proteases and oxygen  radicals,       ii) they are the predominant leukocytes in gingival pocket  epithelium and       iii) their numbers increase with inflammation.</p>
<p><br class="spacer_" /></p>
<p>This       thesis is based on the concept of a host specific and  tissue-destructive       type of inflammatory reaction mediated by hyperreactive  neutrophils. The       aim was thus, to evaluate whether there is an association between       neutrophil activity and attachment loss in periodontitis.</p>
<p>The       fluid in the gingival crevices (GCF) showed a higher neutrophil  elastase       activity (chromogenic substrate) and a lower a-2-macroglobulin       content per µL (ELISA) in sites with tissue destruction than in  sites       without destruction in patients with gingivitis alone (Papers I  and II).       The lower concentration of the protease inhibitor can be ascribed  to       greater consumption due to the release of a larger amount of  active       proteases -e.g., neutrophil elastase.</p>
<p>In       Paper III, the elastase activity in GCF was related to the  lactoferrin       content (ELISA). Elastase was used as a marker of neutrophil  activation       and lactoferrin as a marker of the number of neutrophils in the  area. A       higher elastase/lactoferrin ratio in GCF from periodontitis  patients was       found even when the samples were taken from clinically similar  sites       -i.e., the release of elastase per cell was higher from  neutrophils in       periodontitis patients than that in patients with gingivitis  alone. This       accords with a neutrophil associated specific host response.</p>
<p>This       conclusion was further supported by the finding of lower protein       concentrations in GCF from patients with periodontitis regardless  of the       clinical status (Gingival Index and pocket depth) of the sampled  site (Paper       IV ).</p>
<p>The       methodological evaluation in Paper V showed that it was not  possible to       recover pure elastase from the paper strips used for sampling in  the       previous papers. The elastase a-2-macroglobulin        complex could be recovered. The elastase activity determined on  low       molecular substrates must therefore originate from the elastase a-2-macroglobulin       complex.</p>
<p>In       order to verify the conclusions in previous papers (I-III)  concerning       hyperreactive neutrophils in periodontitis, an <em>in  vitro </em>activation of peripheral neutrophils was performed (Paper       VI). Using luminol-enhanced chemiluminescence, a higher release of  oxygen       radicals from neutrophils activated after Fc-receptor stimulation  was       found in patients with periodontitis. The elastase release was  also       significantly higher when related to the simultaneous release of       lactoferrin.</p>
<p><em>In conclusion,</em> both <em>in vivo </em>and <em>in vitro</em> findings  in this thesis show an association between       neutrophil activity and tissue destruction in periodontitis. This       corroborates the view that there is a tissue-destructive type of       inflammatory reaction, mediated by hyperreactive neutrophils.</p>
<p><br class="spacer_" /></p>
<p><em>Key words</em>:       Periodontitis, inflammation, specific host response,  tissue-destruction,       neutrophils, free oxygen radicals elastase, GCF</p>
<p><br class="spacer_" /></p>
<p><strong>ISBN        91-628-1510-5</strong></p>
<p><br class="spacer_" /></p>
<p><strong>CONTENTS </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Preface </strong>5<strong> </strong></p>
<p><strong>Introduction </strong>6<strong> </strong></p>
<p><strong> </strong>Periodontitis       &#8211; a host response disease                                                                            6</p>
<p>Neutrophilic granulocytes                                                                                                11</p>
<p>Neutrophil mediated tissue destruction in periodontitis                                                  14</p>
<p><strong>Aims </strong>16<strong> </strong></p>
<p><strong>Methods </strong>17<strong> </strong></p>
<p>Clinical parameters                                                                                                                 17</p>
<p>Sampling of gingival fluid                                                                                                17</p>
<p>Gingival crevicular fluid volume                                                                                         17</p>
<p>Elastase activity                                                                                                                 17</p>
<p>Antigenic elastase                                                                                                             18</p>
<p>Lactoferrin and a-2-macroglobulin content                                                                        18</p>
<p>Total protein content                                                                                                             18</p>
<p>Chemiluminescence                                                                                                        19</p>
<p>Neutrophil preparation                                                                                                       19</p>
<p>Neutrophil activation                                                                                                          20</p>
<p>Flow cytometric analysis                                                                                                          20</p>
<p><strong>Investigations and results </strong>21<strong> </strong></p>
<p><strong> </strong>Studies       on the pathogenesis of periodontitis                                                                   21<strong> </strong></p>
<p><strong> </strong>Paper       I                                                                                                                               22</p>
<p>Paper II                                                                                                                          24</p>
<p>Paper III                                                                                                                                  26</p>
<p>Paper IV                                                                                                                                      28</p>
<p>Paper V                                                                                                                              30</p>
<p>Paper VI                                                                                                                        32</p>
<p><strong>General discussion </strong>34<strong> </strong></p>
<p><strong>Conclusions </strong>40</p>
<p><strong>Acknowledgements </strong>41<strong> </strong></p>
<p><strong>References </strong>42<strong> </strong></p>
<p><strong>Papers I-VI </strong></p>
<p><strong> </strong></p>
</td>
<td width="6"></td>
</tr>
<tr>
<td width="22"></td>
<td width="624">
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>PREFACE</strong><strong> </strong></p>
<p><br class="spacer_" /></p>
<p>The thesis is based on the  following       publications, which will be referred to in the text by their Roman       numerals.</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>I                         Granulocyte elastase in gingival crevicular fluid</strong></p>
<p>A possible discriminator between gingivitis and  periodontitis</p>
<p>Gustafsson A., Åsman B., Bergström K. &amp; Söder P.-Ö.</p>
<p>Journal of Clinical Periodontology 1992; 19: 535-540</p>
<p><br class="spacer_" /></p>
<p><strong>II                    Altered relation between granulocyte elastase and a-2- </strong></p>
<p><strong> macroglobulin in gingival crevicular fluid from sites with        periodontal destruction </strong></p>
<p>Gustafsson A., Åsman       B. &amp; Bergström K.</p>
<p>Journal of Clinical Periodontology 1994; 21: 17-21</p>
<p><strong> </strong></p>
<p><strong>III                Elastase and lactoferrin in gingival crevicular fluid:  possible  indicators of       a granulocyte-associated specific host response </strong></p>
<p>Gustafsson A., Åsman       B. &amp; Bergström K.</p>
<p>Journal of Periodontal       Research 1994; 29: 276-282</p>
<p><br class="spacer_" /></p>
<p><strong>IV                  Lower protein       concentration in GCF from patients with        periodontitis: an indicator of host-specific inflammatory       reaction </strong></p>
<p>Gustafsson A., Åsman B. &amp; Bergström K.</p>
<p>Journal of Clinical Periodontology 1995; 22: 225-228<strong> </strong></p>
<p><br class="spacer_" /></p>
<p><strong>V                         Methodological considerations in GCF sampling with                      paper strips: poor recovery of uncomplexed elastase </strong></p>
<p>Gustafsson A. Submitted to Journal of Clinical  Periodontology</p>
<p><br class="spacer_" /></p>
<p><strong>VI                         Increased release of free oxygen radicals from peripheral                      neutrophils in adult periodontitis after Fc-gamma                      receptor stimulation. </strong></p>
<p>Gustafsson A. &amp; Åsman B.</p>
<p>Journal of Clinical Periodontology 1996; in print <strong> </strong></p>
<p><strong> </strong></p>
<p><strong>INTRODUCTION </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong>“This form of destructive  pericementitis       is as fatal in</p>
<p>its results as       inflammation from deposits of calculus.</p>
<p>It usually runs a more       rapid course, I think, and is less</p>
<p>amenable to treatment.”</p>
<p>G. V. Black 1882</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Periodontitis  &#8211; a host       response disease </strong></p>
<p><br class="spacer_" /></p>
<p>Periodontitis       is a tissue-destructive inflammation that affects some sites in  certain       individuals (Lindhe et al. 1983, Socransky et al. 1984). The tooth       supporting collagen fibres of the periodontal ligament may be  broken down       by neutrophils alone or in concert with other cells -e.g.,  monocytes/macrophages       and fibroblasts, in the vicinity of the periodontal lesion.        The destruction is probably mediated by a specific host  response       that is a prerequisite for the inflammation to become destructive  on       bacterial challenge. The view that the tissue destruction is  mediated by       the host’s cells and not by bacteria is supported by the findings  that       anti-inflammatory drugs reduce attachment loss, but do not affect  the       microbiota (Williams et al. 1989) and that sterile granulation  tissue       degrades collagen in the absence of bacteria (Åsman et al. 1988).</p>
<p>The       assumption of a specific host response is supported by epidemiological studies,       that show       that the frequency of moderate to severe periodontitis is in the  order of       5-10% in most parts of the world, independently of oral hygiene  habits (Yoneyama       et al. 1986, Hugosson et al. 1992). In areas with little, if any  oral       hygiene, higher amounts of plaque and dental calculus, and higher       frequencies of gingivitis have been reported, but the majority of  the       population still do not develop periodontitis (Bealum et al. 1986,  1988).       Moreover, in families with a high frequency of early onset  periodontitis,       there is a genetic coupling, indicating that periodontitis is a  patient       associated specific host response (van der Velden 1990,  Michalowicz<strong> </strong>1991).</p>
<p>In       conclusion, the idea of a specific host response expressed, as a  tissue-       destructive inflammation, is well supported while the involvement  of       specific pathogens is less clear.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong>Microbiology</strong></p>
<p>Although       numerous studies have been published that suggest a relationship  between       the microbiota and the clinical status of the gingival pocket, it  is still       difficult to point out a single specific periopathogen. Wolff et  al.       (1993) found, in agreement with others (e.g., Socransky et al.  1991, Beck       et al. 1992), that the frequency and the levels of<strong> </strong>five Gram-negative anaerobic bacteria, previously known to  increase       with the severity of the disease, correlated with the probing  depth of       6905 sites sampled. This could be either an indicator of disease  or simply       the result of a more favourable environment. Deep pockets favour  anaerobic       bacteria, such as <em>P. gingivalis, P.       intermedia, E. corrodens </em>and <em>F.       nucleatum</em>, but these bacteria can also be found in shallow  pockets,       even in subjects without deep pockets or periodontits (Dahlén et  al.       1992, Chen et al. 1989). Wolff et al. (1993) conclude that the  fact that       the alleged periopathogens frequently inhabit sites that are not       associated with advanced disease suggests that a susceptible host  is       required.</p>
<p>Since       the environment influences the bacterial composition, it should be  more       interesting to compare the microbiological flora in clinically  similar       sites with and without progression. Studies done with this design  have       shown conflicting results. Dzink et al. (1988) studied 33 subjects  with       periodontal disease and compared the predominant cultivable flora  in 100       active sites (attachment loss of at least 2 mm in two months) with  that in       150 inactive sites with similar pocket depth and attachment level.  They       found a significantly increased frequency of <em>F.       nucleatum </em>and <em>W. recta</em><strong> </strong>in  active sites and suggested that combinations of some species       above certain threshold levels might initiate active periodontal  disease.</p>
<p>Haffajee       et al. (1991) studied six sites per tooth (excluding third molars)  in 38       subjects with attachment loss. The total average viable count at  each site       in each subject was averaged in subjects with active disease, who       exhibited one or more sites with an attachment loss of 3 mm or  more, and       in those with inactive disease. Those with active disease had  higher       frequencies of <em>P. gingivalis </em>and       <em>W. recta</em>, while those with inactive disease had  higher frequencies       of <em>C. ochracea </em>and <em>Capnocytophaga</em> sp. These authors used the mean frequency of various  microorganisms in the       sampled sites to characterize each subject and they concluded that  “ the       present investigation suggested certain species which might be  useful in       identifying subjects at risk”.</p>
<p>Moore       et al. (1991) compared the microbial flora in samples from sites  with       disease progression (-i.e., an attachment loss of 2 mm or more  during the       last two months) with the flora in clinically similar control  sites with       no disease progression, obtained at the same time from the same  subject.       No significant difference was found between the two types of  sites.       Similarly MacFarlane et al. (1988) and Liljenberg et al. (1994)  were       unable to detect differences between sites with or without  progression in       untreated patients with adult periodontitis. The latter authors  ascribed       the inability to find                              microbial differences to methodological reasons, such as  smallness       of the samples, or the delineation of only a few species,        or in fact no difference in the subgingival microbiota that  could       explain the differences in disease progression.<strong> </strong></p>
<p>Although       numerous microbiological studies have been performed, the  association       between specific periopathogens and periodontitis remains to be       conclusively proved and it is not yet possible to state whether  the       microbiota found in deep pockets are the cause or an effect of       periodontitis. This also applies to a relation between progression  of the       disease and certain bacteria. An intriguing question concerns the  way in       which the periodontal process starts. The theory that specific       periopathogens may be involved in the causation of periodontitis  does not       explain the development of a tissue destructive inflammation in  normal       gingival cervices, in some sites and in certain individuals. It  therefore       seems important to study the normal supragingival microflora which       contains considerable amounts of Gram-negative bacteria.<strong> </strong></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Aggravating factors</strong></p>
<p>Three       fairly common conditions, show an increased prevalence of  periodontitis:       diabetes, human immunodeficiency virus infections and Down’s  syndrome.       All three are associated<strong> </strong>with       alterations in the immune system that significantly affect the       inflammatory reaction and show dysfunctions in the neutrophils.</p>
<p><br class="spacer_" /></p>
<p><em>Diabetes</em> has proved to be a risk factor for periodontitis. Recent  epidemiological       studies report an increased prevalence and increased incidence of       periodontitis (Grossi et al. 1993, Haber et al. 1991, Yalda et al.  1994).       Although the results of examinations of the periodontal microflora  are       conflicting, most studies indicate that there are no differences  in the       microbiota between periodontitis patients with or without  diabetes. It       therefore seems reasonable to assume that the high frequency of       periodontitis is due to an aberrant host response. Diabetes may  increase       susceptibility to periodontitis by impairing neutrophil chemotaxis  and       phagocytosis (Manouchehr-pour et al. 1981, McMullen et al. 1981).  Abnormal       cross-linking and glycosylation of collagen and defective  secretion of       growth factors may also contribute to the increased susceptibility  of       patients with diabetes (Yalda et al. 1994). Monocytes from  patients with       diabetes secrete more prostaglandin E2       (PGE2) and interleukin 1b       after stimulation with       lipopolysaccharide (LPS). This accords with the finding of an        increased secretion of PGE2       from monocytes after LPS stimulation in patients with early-onset       periodontitis (Shapira et al. 1994) and elevated levels of PGE2       in gingival crevicular fluid (GCF) from       patients with periodontitis  (Offenbacher       et al. 1991).</p>
<p><br class="spacer_" /></p>
<p><em>Human       immunodeficiency virus </em>(HIV) is       associated with distinguished forms of gingivitis and  periodontitis.       HIV-associated gingivitis is characterized by a distinctive type  of       marginal gingivitis accompanied by petechia-like or diffuse  erythematous       lesions of the attached gingiva and oral mucosa, which do not  respond to       conventional treatment and improved plaque control (Murray 1994).  The       clinical features of HIV-associated periodontitis include severe  pain,       spontaneous gingival bleeding, and exposure of        bone (Murray 1994). The microbiota of        HIV-associated periodontitis resembles that usually found  in       periodontitis patients without HIV. In contrast, the microbiota of       HIV-associated gingivitis differs entirely from that seen in other       subjects with gingivitis and the flora resembles that encountered  in       periodontitis lesions (Murray et al. 1989). HIV infection causes  many       changes in the immune system -e.g., neutrophils show decreased  chemotaxis       but increased phagocytosis and respiratory burst (Ryder et al.  1988).</p>
<p><em> </em></p>
<p><em>Down’s       syndrome</em>. The prevalence of       periodontitis in<em> </em>patients with <em>Down’s  syndrome </em>(DS) is very high and exceeds 90% in some studies       (Reuland-Bosma &amp; van Dijk 1986, for review).  In  a more recent Swedish study, alveolar bone loss was found       in 39% of children (10-19 yrs) with Down’s syndrome (Modéer et al.       1990). The reason for this high prevalence is not clear, but DS is       associated with many changes in the immune system -e.g., a  decrease in the       number of mature T-lymphocytes and functional defects in the  neutrophils.       Impaired chemotaxis and phagocytosis are present but the findings       concerning respiratory burst are inconclusive (Kretschmer et al.  1974,       Barkin et al. 1980 a, b). Preliminary results in our laboratory  indicate       that the extracellular release of free oxygen radicals from  peripheral       neutrophils in children with DS but without periodontitis is  similar to       that in healthy control subjects. However, in DS patients with       periodontitis the release of oxygen radicals seems to be higher,  which is       in accordance with the findings in juvenile periodontitis (Åsman  1988).       Reuland-Bosma &amp; van Dijk (1986) suggest that the reason for  the high       prevalence in DS is a combination impaired collagen synthesis and  abnormal       capillary morphology as well as due to functional defects in  neutrophils       and monocytes.</p>
<p><em> </em></p>
<p><em>Quantitative        and qualitative defects in the neutrophils</em> have been implicated as the cause of the periodontal tissue  destruction in       a number of rare and more or less life-threatening diseases, such  as the       Chediak-Higashi syndrome, Papillon-Lefévre syndrome, acute myeloid  and       chronic leukaemia  (Wilton et       al. 1988, for review). Another unusual and very serious condition       associated with periodontitis is leukocyte adhesion deficiency  (LAD) (Meyle       1994). Neutrophils from patients with LAD show defects in three  adhesion       molecules, LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18) and gp 150,95       (CD11c/CD18), probably due to a primary defect in the common beta  subunit       (CD18). These three integrins mediate vital leukocyte functions,  such as       binding to endothelial cells, chemotaxis and phagocytosis.  Considering the       severity of this deficiency, the associated prepubertal  periodontitis can       be seen as a complication of LAD rather than a form of  periodontitis.</p>
<p>Other conditions, such as  physical       and psychical stress (Green et al. 1986) and malnutrition (Enwonwu  1994)       may impair protective responses, such as production of  antioxidants and       acute phase proteins, and can, as such, aggravate periodontitis  but not       cause destructive inflammation <em>per       se</em>.<span style="text-decoration: underline;"> </span></p>
<p><br class="spacer_" /></p>
<p><em>Smoking </em>is now accepted as an additional       risk factor for periodontal disease. Several epidemiological  studies have       demonstrated an increased prevalence of periodontitis among  smokers (Haber       &amp; Kent 1992, Holm 1994, for review see, Bergström &amp; Preber  1994).       Periodontal treatment, both surgical (Preber &amp; Bergström 1990)  and       non-surgical (Preber &amp; Bergström 1985), is less effective in  smokers.       Smokers have also been shown to be highly over-represented in the  groups       of patients with refractory periodontitis studied by MacFarlane et  al.       (1992) and Magnusson et al. (1994).</p>
<p>The pathogenetic  mechanisms       underlying this are not clear. Patients with periodontitis who  smoke do       not differ from those who do not, with respect to possible  periopathogens       (Preber et al. 1992). In subjects with gingivitis, there are no       differences between smokers and non-smokers, either in the  composition of       the microbiota or in the plaque accumulation rate (Bergström &amp;  Preber       1994). Smoking causes several changes in the inflammatory response  &#8211; for       example, tobacco smoke and water soluble components of tobacco  smoke       impair the chemotaxis and phagocytosis of normal peripheral  neutrophils (Kenney       et al. 1977, Kraal &amp; Kenney 1979). Cigarette smoking increases  the       number of circulating neutrophils <em>in vivo </em>and  increases the release of reactive oxygen radicals from       peripheral neutrophils  <em>in       vitro</em> (Anderson et al. 1987, Anderson et al. 1991).</p>
<p><em> </em></p>
<p><em>In       conclusion</em>, patients who have       conditions associated with an elevated prevalence of periodontitis  seem to       have a compromised host response with alterations in neutrophil  functions.       <span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Neutrophilic       granulocytes </strong></p>
<p>In man, the neutrophilic  granulocyte       is the predominant leukocyte in blood comprising between 50% and  70 % of       the circulating pool of leukocytes. The neutrophils are produced  in the       bone marrow, where the myeloid precursor cells mature to segmented       neutrophils in about 9 days. The cells remain in the blood­stream  for a       relatively short time (T1/2 = 6-7h)       and in the tissue for 1-4 days. The neutrophils are rapidly  mobilized to       the site of an injury or bacterial invasion (within 30 min) and  constitute       the first cellular host defence against invading bacteria.</p>
<p>Migration from the blood  vessels (diapedesis)       to the inflammatory lesion starts with binding between the  selectins (P-       and E-selectin on the endothelial wall, and L-selectin on the  neutrophil)       and their counter-receptors (ligands). This initiates the rolling  of       neutrophils along the wall and enables the cells to come into  contact with       chemoattractants along the endothelial lining of the vessels. The  contact       with chemoattractants triggers intracellular reactions which  activate the       integrin adhesiveness (Springer 1994). The neutrophils adhere to  and       penetrate the endothelial layer by binding integrins on their  membranes (LFA-1,       Mac-1, VLA-4) with the intercellular adhesion molecules on the  endothelium       (ICAM-1, ICAM-2, VCAM-1). Besides activating the integrins, the       chemoattractants direct the migration of the cell once it is  outside the       blood vessel. The neutrophils can sense a chemoattractant  concentration       gradient of 1% across their diameter and move, using the integrins  for       traction, towards the inflammatory lesion.</p>
<p>In the gingival sulcus,  the       neutrophils form a “leukocyte wall” between the subgingival plaque  and       the junctional epithelium (Frank et al. 1980). The neutrophil  recognizes       and combats foreign substances by their receptors for several  surface       structures -for instance, the Fc-portion of attached antibodies,       complement factors, capsule reactive proteins and the LPS-complex.</p>
<p>Neutrophils can deliver       antimicrobial substances by four mechanisms:</p>
<p>1. <em>Degranulation</em> releases anti-bacterial substances extracellularly (Wright 1988),  from        primary (azurophil) granule: defensins, lysozyme,  myeloperoxidase       and the neutral serine proteases cathepsin G and elastase, and  from       secondary (specific) granule: lactoferrin, collagenase and  lysozyme. A       tertiary granula containing gelatinase has been described (Dewald  et al.       1982).<strong> </strong></p>
<p>2)       <em>The respiratory burst</em> releases       highly reactive oxygen metabolites extracellularly.        Oxidative metabolism mainly generates hypochlorous acid  (HOCl)       because of the relatively high concentration of Cl-       in plasma (Weiss 1989), which has both tissue-destructive  and       antimicrobial effects.</p>
<p>3) <em>Phagocytosis,</em> which isolates the organism intracellularly by creating a  phagosome.<strong> </strong>Fusion between the phagosome and cytoplasmic granules result  in the       delivery of high concentrations of the antibacterial substances  mentioned       above into the vacuole.</p>
<p>4) <em>Cytolysis</em> or apoptosis (programmed cell death) is an ultimate mechanism for        antibacterial substances to reach the bacteria. Considering  the       high concentration of neutrophils in inflamed tissue, the release  of       antibacterial agents from dying cells may represent an important  host       defence mechanism (McNamara et al. 1988).</p>
<p><br class="spacer_" /></p>
<p>The neutrophil, however,  is not only       a terminally differentiated cell, incapable of protein synthesis,  that       participates in the inflammatory response only as an effector cell  by       releasing preformed substances. It can also produce several potent       inflammatory mediators that may influence both cellular and  humoral       immunity (Table 1) (Lloyd &amp; Oppenheim 1992) . T-cells, natural  killer       cells and monocytes/macrophages produce considerable amounts of  cytokines,       but the vast majority of cells infiltrating an inflamed tissue are       neutrophils and they may thus be an important source of cytokines.  This       capacity enables the neutrophil to survive much longer in the  inflamed       lesion than was previously believed (Cassatella 1995).</p>
<p>In this scenario,  neutrophils should       be considered not only as active and central elements in the  inflammatory       response, but also as cells which, through cytokine secretion, may       significantly influence the direction and development of the  immune       processes.</p>
<p>__________________________________________________________________________</p>
<p>Table       1. Proteins and other mediators produced and released by  neutrophils to       fulfil efferent (effector) and afferent (inductive) functions in       inflammation, immunity and repair.</p>
<p>__________________________________________________________________________</p>
<p><span style="text-decoration: underline;">Mediator</span> <span style="text-decoration: underline;">Reference</span></p>
<p><strong>Efferent</strong></p>
<p>CR1, CR 3, FcR, class 1  MHC                                 Jack &amp; Fearon 1988</p>
<p>IFN-a                                 Shirafuji       et al. 1990</p>
<p>Platelet-activating factor                                 Sisson et al. 1987</p>
<p>Leukotriene B4                                  Sisson et al. 1987</p>
<p>Fibronectin                                 La Fleur et al. 1987</p>
<p>PGE2                                  Herrmann et al. 1990</p>
<p><br class="spacer_" /></p>
<p><strong>Afferent </strong></p>
<p>IL-1b                                  Marucha et al. 1990</p>
<p>TNF-a                                 Dubravec et al. 1990</p>
<p>G-CSF, M-CSF                                  Lindemann et al. 1989</p>
<p>IL-6                                  Cicco et al. 1990</p>
<p>IL-8                                  Bazzoni  et al. 1991</p>
<p>IL-1 receptor antagonist                                 Ulich et al. 1992</p>
<p><strong>__________________________________________________________________________ </strong></p>
<p>Modified from Lloyd &amp;  Oppenheim 1992</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Neutrophil       mediated tissue destruction in periodontitis</strong><strong> </strong></p>
<p><br class="spacer_" /></p>
<p>Neutrophilic granulocytes  are       associated with tissue destruction in a number of chronic  inflammations (Table       2). In periodontitis, neutrophils are the probable mediators of  tissue       destruction because: 1) their numbers increase with inflammation,  2) they       lie close to the collagen fibres of the periodontal ligament and  finally,       3) they are equipped with potent active tissue-destructive  substances,       which they may release in the inflammatory lesion.</p>
<p><em>Increasing       numbers </em>of neutrophils<em> </em>have been reported in several morphologic studies of the inflamed       gingiva. Attström (1970) studied the presence of leukocytes in  clinically       healthy and chronically inflamed sites in humans and dogs. The  leukocytes       were found in healthy as well as in inflamed sites and  differential counts       showed 95-97% neutrophils, 1.2% lymphocytes and 2-3% moncytes. The       proportions remained the same, although the number of leukocytes  increased       with inflammation. In another study by the same author (Attström  1971),       leukopenia was induced by nitrogen mustard and heterologous       anti-neutrophil serum in dogs with chronically inflamed gingiva.  The       leukopenia caused a reduction in the number of crevicular  leukocytes, the       enzymatic activity and the volume of gingival crevicular fluid.  Kowashi et       al. (1979) counted neutrophils in gingival washings during  experimental       gingivitis in man and found a doubling of the number of cells from  day 0       to day 20.</p>
<p><em>The       localization </em>of neutrophils near  Sharpey’s       fibres and the formation of a leukocyte wall have been shown in       microscopic studies. Christersson et al. (1987), using light and       immunofluorescence microscopy, noted extensive subepithelial  infiltration       of neutrophils in gingival biopsies from patients with juvenile       periodontitis. Frank et al. (1980), using transmission microscopy,  found a       wall of aggregated neutrophils between the subgingival plaque and  the       junctional epithelium.</p>
<p><br class="spacer_" /></p>
<p><em>The       degranulation </em>of the  neutrophils, leads to       the release of active and inactive proteases extracellularly.  Elastase is       a neutral serine protease that can degrade a number of important  proteins       in the extracellular matrix, such as elastin, fibronectin and  collagen       types I, II, III and IV (Starkey et al. 1977, Janoff 1985).  Collagenase (matrix       metallo-proteinase-8) is released in a latent form but can be  activated       extracellularly. Several authors have demonstrated the presence of       neutrophil-derived collagenase, both functionally and       immunohistochemically, in  gingival       tissue biopsies and gingival crevicular fluid (GCF) (Gangbar et  al. 1990,       Overall et al. 1991, Ingman et al. 1994). The destructive capacity  of       released proteases is usually offset by the protease-inhibitors a-1-antitrypsin       (A1AT) and a-2-macroglobulin       (A2MG). The inhibitors are present in such abundance that all  active       proteases are inhibited within milliseconds, but the release of  proteases       in closed compartments and/or an oxidative inactivation of A1AT  can give       the proteases an opportunity to cause tissue damage.</p>
<p><em>The       respiratory burst</em> generates       reactive oxygen radicals that are released extracellularly. Oxygen       radicals are tissue destructive <em>per       se </em>(Weiss 1989), but they       can also act in concert with the simultaneous release of  proteases.       Extracellularly released oxygen radicals can oxidatively inhibit  A1AT       and       thus allow the proteases to degrade matrix proteins in close  proximity to       the neutrophils (Weiss 1989). Neutrophil collagenase, released  from the       cell in an inactive form, may be activated by the simultaneous  release of       oxygen radicals (Saari et al. 1990).</p>
<p>Oxygen radicals, besides       contributing to the tissue destruction, are also thought to  inhibit       phagocytosis (Stendahl et al. 1984). The mechanism for this is  unclear:       both the receptors on the neutrophils and their ligands may be  affected.</p>
<p><em>In       conclusion</em>, neutrophils may play a       major role in the tissue-destructive mechanisms causing  degradation of the       periodontal ligament in periodontitis.</p>
<p>_________________________________________________________________________</p>
<p>Table       2.  Noninfectious conditions       in which symptoms and tissue injury may be partly mediated by  neutrophils</p>
<p>__________________________________________________________________________</p>
<p><strong>Disease</strong> <strong>Reference</strong></p>
<p><br class="spacer_" /></p>
<p>Adult respiratory distress       syndrome                                 Rivkind et al. 1991</p>
<p>Cystic fibrosis                                 Kharazmi et al. 1987</p>
<p>Emphysema                                  Janoff 1983</p>
<p>Glomerulonephritis                                 Holdsworth &amp; Bellomo 1984</p>
<p>Inflammatory bowel disease                                 Faden &amp; Rossi 1985</p>
<p>Myocardial infarction                                 Rowe et al. 1984</p>
<p>Rheumatoid arthritis                                 Nurcombe et al. 1991</p>
<p>Secondary  hyperparathyroidism                                 Tuma et al. 1981</p>
<p>Trauma                                  Tanaka et al. 1991</p>
<p>__________________________________________________________________________</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
</td>
<td width="6"></td>
</tr>
<tr>
<td width="22"></td>
<td width="624">
<p><strong>AIMS </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>General       aims </strong></p>
<p>The investigations in this  thesis       were based on the concept that periodontitis is caused by a host  specific       tissue-destructive type of inflammatory reaction that is  associated with       hyperreactive neutrophils. The aims were thus to demonstrate an       association between neutrophil activation and attachment loss. <strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Aims       of studies included in thesis: </strong></p>
<p><strong> </strong></p>
<p><strong>- </strong>to  measure       the enzymatic activity and the antigenic content of elastase in  GCF in       order to distinguish between periodontitis and gingivitis.</p>
<p><br class="spacer_" /></p>
<p>- to study the local  balance between       elastase activity and a-2-macroglobulin        in GCF-samples from various types of gingival sites and to relate  these       components to tissue-destructive inflammation.</p>
<p><br class="spacer_" /></p>
<p>- to relate elastase  activity to the       amount of lactoferrin in order to assess the local reaction of  neutrophils       from patients with periodontitis and patients with gingivitis.</p>
<p><br class="spacer_" /></p>
<p>- to compare the protein       concentration in GCF from 1) inflamed sites with or without tissue       destruction from patients with periodontitis and 2) inflamed sites  from       patients with gingivitis alone.</p>
<p><br class="spacer_" /></p>
<p>- to assess the recovery  of certain       proteins from paper strips and evaluate the usefulness of various  sampling       methods for analyses of GCF.</p>
<p><br class="spacer_" /></p>
<p>- to measure the <em>in vitro</em> generation of oxygen radicals and degranulation  from       peripheral neutrophils in patients with adult periodontitis and  pair       matched healthy controls in order to evaluate the association  between       neutrophil reactivity and periodontal tissue destruction.</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>METHODS </strong></p>
<p><strong> </strong></p>
<p><strong>Clinical       parameters</strong><span style="text-decoration: underline;"> </span></p>
<p>Supragingival plaque (PLI)  and       gingival inflammation (GI) were recorded employing the criteria of  Silness       &amp; Löe (1964) and Löe (1967) (Papers I-IV). Only sites with a  GI       value of 1 or 2 were used. Sites without inflammation (value 0)  could not       yield sufficient gingival crevicular fluid (GCF) volumes to permit       measurement with the Periotron 6000® and very inflamed sites (GI  value 3)       usually could not be examined because it was difficult to avoid       contamination of the GCF sample by blood.</p>
<p>Pocket depth and clinical  attachment       level, the distance from the enamel-cement junction to the bottom  of the       pocket, were measured with a calibrated periodontal probe. The  marginal       bone loss (MBL) was recorded in accordance with the  recommendations of       Lavstedt &amp; Eklund (1975) (Paper I)and adjusted for age by  subtracting       of the means for the corresponding age group reported by Lavstedt  et al.       (1975).<span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><strong>Sampling       of gingival crevicular fluid</strong><span style="text-decoration: underline;"> </span></p>
<p>The       site to be sampled was isolated with cotton rolls, supragingival  plaque       removed and the site was gently dried with an air syringe (Papers  I-IV).       Thirty seconds later, GCF was collected with prefabricated paper  strips (Periopaper       ® GCF strips, IDE Interstate, Amityville, NY, USA). The strip was       inserted into the pocket until mild resistance was felt and was  kept there       for 30 sec.</p>
<p><span style="text-decoration: underline;"> </span></p>
<p><strong>Gingival       crevicular fluid volume</strong></p>
<p>The volume of the GCF was measured with a       Periotron 6000® GCF meter (IDE       Interstate, Amityville, NY, USA) (Papers I-IV). The Periotron  measures the       elec­trical capacitance as the dielectric insulating properties of  the       filter paper vary with the quantity of fluid absorbed by the  paper.       Differences in the composition of the various GCF samples do not  affect       the measurements (Hinrichs et al. 1984). Before each study, the  instrument       was calibrated with saline, delivered with a Hamilton syringe.</p>
<p><span style="text-decoration: underline;"> </span></p>
<p><strong>Elastase       activity</strong><span style="text-decoration: underline;"> </span></p>
<p>The amount of active  elastase (Papers       I-VI) was measured as proteolytic activity on a low molecular  weight       substrate, (445.5 Da) L-pyroglutamyl-L-propyl-L-valine-<em>p</em>-nitroanilide        (S-2484, Pharmacia Diagnostica, Uppsala, Sweden). The substrate is  highly       specific for granulocyte elastase (Tanaka et al. 1990) but is also       hydrolysed by the elastase-a-2-macroglobulin        complex (Wewers 1988). No difference in activity was found between  pure       commercial elastase and the elastase a-2-macroglobulin       complex.</p>
<p><span style="text-decoration: underline;"> </span></p>
<p><strong>Antigenic       elastase</strong><span style="text-decoration: underline;"> </span></p>
<p>The antigenic elastase  (Paper I) was       assessed by a commercial method (PMN elastase IMAC MERCK # 11332),  which       measures both free elastase and the elastase-a-1-antitrypsin       complex. The elastase is detected with a sheep antibody, against  human       neutrophil elastase, conjugated with inactive peroxidase. The  enzyme is       activated by the antigen antibody reaction.</p>
<p><br class="spacer_" /></p>
<p><strong>Lactoferrin       and a-2-macroglobulin </strong></p>
<p>An Enzyme Linked  Immunosorbent Assay       (ELISA) was used to analyse the contents of lactoferrin and a-2-macroglobulin       (Papers II, III, V, VI). The micro-well plate was coated with the  antigen,       samples or standard, diluted in carbonate buffer, pH 9.6,  overnight at +4°C.       After incubation, the plate was washed four times with PBS 7.4 +  0.05%       Tween 20. The antigen was detected with a polyclonal rabbit  antibody       during incubation at +37°C for 1h. After another washing with PBS +  Tween,       the final antibody, a goat anti-rabbit IgG conjugated with  alkaline       phosphatase (ALP), was added. The plate was once again incubated  at +37°C       for 1h and washed as above. The ALP activity was measured with the       substrate p-nitro-phenol-phosphate in a spectrophotometer at 405  nm.</p>
<p>In Paper VI, the amount of       lactoferrin was analysed with a sandwich ELISA, using a monoclonal  mouse       anti-lactoferrin antibody as the first antibody. This antibody was  coated       on the plate overnight and the antigen was added after four  washings.       After incubation for 1h at +37°C, the procedure was the same as  described       above.</p>
<p>Each plate included a  standard curve       obtained by the serial dilution of a commercial standard. <strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Total       protein content</strong></p>
<p>The protein content of GCF  was       measured with a protein staining method described by Bradford  (1976),       using the Bio Rad protein assay (Bio Rad Laboratories GmbH,  Munich,       Germany) (Papers IV, V). The method is sensitive and reproducible,  but       stains vari­ous amino acids differently. This protein staining  method       seems to be particularly sensitive to arginine rich proteins  (Compton       &amp; Jones 1985). To minimize the risk of differences in the  staining of       various proteins, a standard serum (Control serum, Behringwerke  AG,       Marburg, Germany), with a pro­tein composition similar to GCF, was  used       as standard.<span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><strong>Chemiluminescence </strong></p>
<p>Chemiluminescence (CL) is a       convenient and sensitive way to measure the respiratory burst.  Native CL       is the light produced by the neutrophil during its in­teraction  with       bacteria or other particles (Paper VI). The oxygen consumption,  catalysed       by the membrane enzyme NADPH-oxidase, during this interaction  generates       unstable products, such as superoxide, hydrogen peroxide, singlet  oxygen        and hydroxyl radical. The light emitted results from a  reaction       between oxygen radicals and regions of high electron density in a  wide       range of substrates. Microorganisms in phago­cytic vacuoles  provide a       rich source of oxidizable substrates (for review, see Seymour et  al.       1986). Cyclic hydrazine 5-amino-2, 3 dihydro-1,4 phthalazine­dione  (luminol)       is used as a substrate for the oxygen radicals to enhance the  amount of       light, thus making it possible to use smaller numbers of  neutrophils.</p>
<p>CL correlates well with  the killing       of Staphylococcus aureus initially but, after a prolonged  incubation, the       CL decreases, while the killing rate remains stable (Ewetz et al.  1981). <span style="text-decoration: underline;"> </span></p>
<p><strong> </strong></p>
<p><strong>Neutrophil       preparation </strong></p>
<p>The neutrophils (Papers  III, VI)       were prepared on a two-layer discontinuous Percoll®       gradient (1.098 kg / L ± 1 g and 1.079 kg / L ± 1 g). Nine mL of  venous       blood were layered on the gradient and centrifuged. After an  initial       centrifugation at 108g for 8 min, the supernatant containing  plasma and       platelets, could be removed and after a second centrifugation at  1200g for       10 min, the neutrophils could be separated from the mononuclear  cells. The       erythrocytes in the pellet were lysed with 0.83% NH4Cl,       supplemented with 0.25% human serum albumin (HSA). The cells were  finally       washed twice with phosphate-buffered saline (PBS) + 0.25% HSA. The  cell       preparation contained 96% neutrophils and 4 % mononuclear cells.  The       remaining erythrocytes were about as numerous as the neutrophils  and the       platelets were no more than 50% of the neutrophils. The recovery  of       neutrophils was more than 75% and 98% of the cells were viable  (Bergström       &amp; Åsman 1993).<strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Neutrophil       activation </strong></p>
<p>In order to obtain a  clear-cut Fcg-receptor       stimulation, the neutrophils (Papers III, VI) were activated with  bacteria,       opsonized with human gamma-globulin. <em> </em> Opsonized <em>Staphylococcus       aureus </em>(S.a.), <em>Actinobacillus       actinomycetemcomitans</em> (A.a.) and <em>Porphyromonas       gingivalis </em>(P.g.) all induce chemiluminescence (CL) from  peripheral       neutrophils <em>in vitro</em>. Åsman       &amp; Bergström (1992) found that the CL after activation with any  of       these three bacteria was higher in patients with juvenile  periodontitis       than in healthy controls and that neither unopsonized bacteria nor       monomeric IgG induced measurable CL. This indicates that the  bacteria       merely serve as carriers for the polymeric IgG. In our studies,  S.a. was       chosen for practical reasons.</p>
<p>The bacteria were  harvested from       agar plates and counted in a Bürker chamber. Opsonization was done  with       IgG at +20°C during agitation for 2h. The opsonized bacteria were  frozen       in aliquots at -70°C.<strong> </strong></p>
<p><strong> </strong></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><strong>Flow       cytometric analysis </strong></p>
<p>Flow       cytometry was performed on 0.5&#215;106 neutrophils        (Paper VI), premixed either with an antibody or with the  corresponding       immunoglobulin as the negative control for 20 min at ±0°C and  washed       twice in PBS before suspension in 500 µL of the same buffer. Using       unconjugated antibodies, a second FITC-conjugated antibody against       mouse-IgG<strong> </strong>was added before       performing the same procedures of incubation, washing and final  suspension.       FITC-conjugated monoclonal antibodies were used against CD15, CD  16, CD       62L (Mel-14) and CD 11b. Unconjugated antibodies were used against  CD 11a       and CD 35. Immunofluorescence was measured on an EpicsR       -profile II Flow Cytometer (Coulter Electronics, Inc., Hialeah,  FL, USA).       The instrument was calibrated on every experimental occasion with  standard       beads for alignment of sheet flow and adjustment of the  photo-multiplier.       After gating of the granulocyte population on the scattergram, the  % of       antigen positive cells and their median immunofluorescence were  registered.</p>
<p><span style="text-decoration: underline;"> </span></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>INVESTIGATIONS AND RESULTS</strong></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><strong>Studies       on the pathogenesis of periodontitis </strong></p>
<p>Pathogenetic studies of       periodontitis have been done for more than a century. Black (1882)  divided       his cases into two types: i) inflammation of the gums occurring  from       deposits of salivary calculus and ii) destructive inflammation of  the       peridental membranes not caused by calcareous deposits. Black  observed       that the destructive inflammation was not related to the general  health of       the patient and that it was more difficult to treat.</p>
<p>Histological studies seem  to have       been based mainly on examinations of biopsy specimens. Despite  technical       and ethical<strong> </strong>sampling       difficulties, this method can give a good picture of the  inflammatory       processes. Histological changes in the gingival tissues from the  initial       lesion to the advanced periodontal lesion are described in a  comprehensive       review by Page &amp; Schroeder (1976).</p>
<p>Many studies are based on  analyses       of plasma components (Schenkein &amp; Genco 1977a, b), lymphocytes  (Lehner       1972) and neutrophils (Van Dyke et al. 1983, Miller 1984) in the  blood.</p>
<p>A convenient and  noninvasive way to       study the pathological processes in the gingival lesion is to  analyse       samples of gingival crevicular fluid (GCF). GCF is primarily a  filtrate of       plasma, but it also contains leukocytes and leukocyte derived  products,       tissue degradation products and microorganisms and their products.  All of       these components may be representative of the inflammatory lesion  and       therefore of interest to analyse (see Cimasoni 1983 for review).  The       possibility of identifying subjects susceptible to periodontitis  and of       predicting the progress of the disease have been investigated  extensively       during recent decades (see Curtis et al. 1989, Page 1992, Lamster  1992,       for review).</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p>In this thesis the       tissue-destructive type of inflammation in periodontitis has been  studied <em>in vivo</em> by analyses of GCF in Papers I-IV and <em>in vitro</em> by functional analyses of peripheral neutrophils  in        Paper VI. A summary of the investigations and results of  the       studies are presented paper by paper on the following pages.</p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;">Paper I </span></p>
<p><strong>Granulocyte       elastase in gingival crevicular fluid</strong>.</p>
<p>A possible discriminator       between gingivitis and periodontitis</p>
<p><br class="spacer_" /></p>
<p>Elastase is released from  the       azurophil granula of the neutrophils during activation and can  therefore       be used as a marker of neutrophil activation in inflammatory  lesions. The       amount of elastase, both functional and antigenic, was therefore  measured       in samples of gingival crevicular fluid (GCF) from inflamed sites  in       patients with adult periodontitis (n=16) and in patients with  gingivitis       alone (n=10). Two deep gingival pockets were sampled in each  periodontitis       patient (mean pocket depth 6.9 mm) and two shallow pockets (2.8  mm) in the       gingivitis group. The two groups of sites had the same gingival  index (Löe       1967). The GCF was collected with paper strips, the volume of the  samples       was measured with a Periotron®, and eluted in PBS with 0.1% Tween  for 1h       and centrifuged at 3000g for 10 min.        Elastase activity was measured with a substrate (S-2484,       L-pyroglutamyl-L-propyl-L-valine-<em>p</em>-nitroanilide)  shown to be highly specific for neutrophil elastase       (Tanaka et al. 1990). The antigenic content of elastase was  determined       with a specific antibody conjugated with peroxidase (PMN elastase  IMAC       Merck # 11332).</p>
<p>The study showed a  correlation       between pocket depth and GCF volume, and between elastase activity  per       site and GCF volume. In order to minimize the influence of the  pocket       depth, the amount of elastase was calculated per µL.        The amount of antigenic elastase showed no difference  between the       two groups, calculated either per site or per µL. In contrast, the       elastase activity, per site and per µL, was significantly higher  in the       periodontitis group  (Fig. 1).<em> </em></p>
<p>The elastase activity per  µL       increased with pocket depth and attachment loss, in spite of  increasing       GCF volume. The higher elastase activity in the periodontitis  sites was  a consequence not only of larger fluid  volumes in the deep       pockets but also of a higher release of elastase per neutrophil  and/or of       higher numbers of enzyme releasing neutrophils in the inflamed  tissue.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Fig.       1</strong></p>
<p><br class="spacer_" /></p>
<p>__________________________________________________________________________</p>
<p><em>Fig. 1. </em>Paper       I. Mean antigenic elastase per µL and elastase activity per µL in  GCF       samples from patients with periodontitis (n=16) and gingivitis  (n=10). *        = <em>p</em> &lt; 0.05 calculated       with the Mann-Whitney U-test. Bars indicate + 1SD</p>
<p><br class="spacer_" /></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;">Paper II </span></p>
<p><strong>Altered       relation between granulocyte elastase and a</strong><strong>-2-macroglobulin        in gingival crevicular fluid from sites with periodontal  destruction </strong></p>
<p><br class="spacer_" /></p>
<p>The elastase substrate  used in Paper       I is hydrolysed not only by free elastase but also by the elastase  bound       to a-2-macroglobulin       (A2MG), which, together with a-1-antitrypsin,        is the principal inhibitor of elastase. These facts made it  interesting to       relate the elastase activity to the amount of A2MG in the same GCF  sample.</p>
<p>Neutrophil elastase  activity and       A2MG were studied in GCF from three categories of sites, in six  patients       with gingivitis alone and six patients with periodontitis. Six  inflamed       sites were sampled in each gingivitis patient and 12 sites, six  with and       six without attachment loss and periodontal pockets in each  periodontitis       patient. These three types of sites were chosen in order to study  the       influence of GI, pocket depth and attachment loss on these two  parameters,       as well as to compare patients with periodontitis to those with  gingivitis       alone. The GCF was collected with paper strips and eluted in 500  µL PBS       for 1h in room temperature, and centrifuged at 3000g for 10 min.  The       volume of the samples was measured with a Periotron 6000®. To       avoid the influence of increased GCF volume from deep pockets  (Paper I),       the elastase activity and the       A2MG content were calculated per µL of GCF. The elastase activity  was       measured with a specific substrate (S-2484) and the A2MG with  ELISA. The       study showed an increase in elastase activity and a decrease in  A2MG  in the sites with attachment loss, but no  difference between       the two types of sites without attachment loss (Fig. 2). The lower       concentration of A2MG in the samples from sites with attachment  loss might       be the result of consumption of the inhibitor due to increased  release of       elastase, since the protease-inhibitor complex is cleared faster  than the       native A2MG (Debanne et al. 1975).</p>
<p>The study showed an  increased       protease activity in sites with tissue destruction, indicating an       association between neutrophil activity and periodontitis,  compatible with       the results of Paper I.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Fig.       2</strong></p>
<p><br class="spacer_" /></p>
<p>__________________________________________________________________________</p>
<p><em>Fig. 2. </em>Paper       II. Clinical attachment loss measured from the enamel-cement  junction to       the bottom of the pocket, elastase activity per µL and a-2-macroglobulin       concentration in three types of sites: GG &#8211; inflamed sites without       attachment loss in subjects with gingivitis alone, GP &#8211; inflamed  sites       without attachment loss and PP &#8211; inflamed sites with attachment  loss in       subjects with periodontitis (n= 6 subjects). The findings in six  sites       were averaged in</p>
<p>each       subject and then the average in all the subjects calculated.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><span style="text-decoration: underline;">Paper III </span></p>
<p><strong>Elastase       and lactoferrin in gingival crevicular fluid: possible indicators  of a       granulocyte-associated specific host response </strong></p>
<p><br class="spacer_" /></p>
<p>The previous studies  (Papers I and       II) showed increased elastase activity in GCF from sites with  attachment       loss, but no difference between clinically similar sites in  patients with       periodontitis and gingivitis alone (Paper II). This may have been  due to       difficulties in assessing the number of neutrophils in the lesion  with the       gingival index (Adonogianaki et al. 1993)<strong>.</strong> In this study lactoferrin, proposed as a marker of the number of       neutrophils (Wright &amp; Gallin 1979, Adonogianaki et al. 1993),  was       related to the elastase activity in the same sample. Initial <em>in       vitro</em> experiments with Fcg-receptor       mediated activation of peripheral neutrophils from healthy  volunteers       showed that the release of elastase and lactoferrin was controlled       independently. It was therefore pertinent to relate the two  substances in       the same GCF sample to obtain an estimate of the release of  elastase       activity per neutrophil.</p>
<p>The samples of GCF were  collected       and eluted in the same way and from the same three types of sites  as in       Paper II. Both the periodontitis and the gingivitis groups  consisted of       seven subjects. The elastase activity was measured with a specific       substrate (S-2484) and the lactoferrin with ELISA.</p>
<p>Higher elastase activity  per µL was       found in sites with attachment loss and deep pockets, in agreement  with       the findings in Papers I and II. Furthermore there was a  significantly       higher activity in the sites without attachment loss from the       periodontitis patients than in the sites from the gingivitis  patients,       although they had similar clinical status, assessed by pocket  depth and       gingival index. Unlike elastase, lactoferrin showed no differences  between       the three types of sites, suggesting that the amounts of  neutrophils were       comparable (Fig. 3). This means that the ratio of elastase to  lactoferrin       was higher in the GCF samples from the patients with  periodontitis,       regardless of the clinical status of the sampled site.</p>
<p>A higher ratio of elastase  to       lactoferrin indicates the occurrence of a higher release of  elastase from       the neutrophils in periodontitis <em>per       se</em>, which strongly suggests a neutrophil associated specific  host       response.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Fig.       3 </strong></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p>__________________________________________________________________________</p>
<p><em>Fig. 3. </em>Paper       III. Elastase activity per µL, lactoferrin concentration and ratio  of       elastase / lactoferrin (mean ± SE) in three types of sites: GG &#8211;  inflamed       sites without attachment loss or deep pockets in subjects with  gingivitis       alone, GP &#8211; inflamed sites without attachment loss or deep pockets  and PP       &#8211; inflamed sites with attachment loss and deep pockets in subjects  with       periodontitis (n= seven subjects).  Six       sites of each type were averaged in each subject and then the  average in       the seven  subjects was       calculated.</p>
<p><br class="spacer_" /></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;">Paper IV </span></p>
<p><strong>Lower       protein concentration in GCF from patients with periodontitis: an       indicator of host-specific inflammatory reaction </strong></p>
<p><br class="spacer_" /></p>
<p>The previous paper showed a       decreased a-2-macroglobulin       concentration in GCF from sites with attachment loss, probably due  to       consumption of the inhibitor because of an increased release of  proteases.       However, an alternative explanation might be dilution of the GCF.  In order       to test this possibility, the protein concentration in GCF was  analysed       with the same experimental design as in Papers II and III.</p>
<p>The GCF samples were       collected with paper strips from six inflamed sites in each of 14  subjects       with gingivitis alone (mean pocket depth 2.0 mm) and from six  inflamed       sites with (mean pocket depth 4.7 mm) and six sites without  attachment       loss (mean pocket depth 2.0 mm) in 13 patients with periodontitis.  The       volume of the GCF samples was measured with a Periotron 6000®. The  GCF       samples were eluted in 500 µL PBS and centrifuged at 3000g for 10  min.       The protein content in the GCF samples was measured by the  Bradford method       (Bradford 1976), using the Bio-Rad protein assay.</p>
<p>The study showed a lower       protein concentration in GCF samples from patients with  periodontitis, in       sites with or without attachment loss, than in GCF samples from  patients       with gingivitis alone (Fig. 4). A weak negative correlation was  found       between the protein concentration and the GCF volume, suggesting  an       increased dilution of the GCF samples from the patients with  periodontitis.       This may result from contributions by the interstitial fluid  (Alfano       1974), which has a protein concentration around 2 g/L compared to  that of       76 g/L in plasma.</p>
<p><br class="spacer_" /></p>
<p>A low protein  concentration seems to       be characteristic of patients with periodontitis and independent  on the       clinical findings at the sampled site. This would accord with a  specific       host response which distinguishes patients with periodontitis from  those       with gingivitis alone.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Fig.       4</strong></p>
<p><br class="spacer_" /></p>
<p>__________________________________________________________________________</p>
<p><em>Fig. 4.</em> Paper       IV. Protein       concentration (µg/ µL) in three types of sites: GG &#8211; inflamed  sites       without attachment loss in subjects with gingivitis alone (14  subjects),       GP &#8211; inflamed sites without attachment loss or deep pockets and PP  &#8211;       inflamed sites with attachment loss and deep pockets in subjects  with       periodontitis (13 subjects).  Six       sites of each type were averaged in each subject and then the  average was       calculated in all the subjects with a given type of site.</p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><br class="spacer_" /></p>
</td>
<td width="6"></td>
</tr>
<tr>
<td width="22"></td>
<td width="624">
<p><span style="text-decoration: underline;">Paper V </span></p>
<p><strong>Methodological       considerations in GCF sampling with paper strips: poor recovery of       uncomplexed elastase </strong></p>
<p><br class="spacer_" /></p>
<p>The       purpose of this study was 1) to measure the recovery of proteins,  as       regards tissue destruction and with a wide range of molecular  weights,       from the paper strips, and 2) to compare the usefulness of  paper-strip       sampling with other sampling methods.</p>
<p>Various       proteins were applied to the strips with a Hamilton syringe and  eluted        in isotonic PBS, pH 7.4, without detergent for 1h and  centrifuged       at 3000g for 10 min. This eluent does not lyse the neutrophils  applied to       the strips, that  may       otherwise release intracellular substances -e.g., neutrophil  elastase &#8211; to       the eluate of the GCF samples. The recovery of these proteins was       satisfactory, about 90% (Table 1), which is in agreement with  earlier       studies (Griffins et al. 1988). However, commercial pure       neutrophil-elastase, unlike the same elastase premixed with a-2-macroglobulin,       could not be recovered from the paper strips. The reason for this  is not       clear, but it was not dependent on the molecular weight in the  range       tested -i.e., 12-725 kD (Table 1).</p>
<p>The recovery of elastase  from       Durapore strips, which are also used for GCF sampling  (Giannopoulou et al       1992), was investigated. About 30% of pure elastase applied to  these       strips was recovered.</p>
<p>However,       a comparison of measurements made with a Periotron 6000®        GCF meter (IDE Interstate, Amityville, NY, USA) on the  Durapore and       the Periopaper strips, showed that Durapore gave lower readings  making it       difficult to measure small volumes of GCF collected with this  material.</p>
<p><br class="spacer_" /></p>
<p>This study showed a  satisfactory and       reproducible recovery of proteins from paper strips, when the  elution was       made in isotonic buffers at neutral pH and without detergents to  minimize       lysis of the neutrophils. However, there was one important  exception: the       recovery of uncomplexed elastase was very low, showing that there  may be       differences between various proteins.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p>_______________________________________________________________________________________</p>
<p>Table       3. Paper V. Recovery of proteins applied to Periopaper strips. n=  number       of determinations, IP = isoelectric point</p>
<p>______________________________________________________________</p>
<p><br class="spacer_" /></p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="227" valign="top">
<p><span style="text-decoration: underline;"> </span></p>
</td>
<td colspan="4" width="341" valign="top">
<p><span style="text-decoration: underline;">MW             (kD)                   IP                          n                                 yield</span></p>
</td>
</tr>
<tr>
<td width="227" valign="top">
<p><span style="text-decoration: underline;"> </span></p>
</td>
<td width="79" valign="top">
<p><span style="text-decoration: underline;"> </span></p>
</td>
<td width="60" valign="top">
<p><span style="text-decoration: underline;"> </span></p>
</td>
<td width="92" valign="top">
<p><span style="text-decoration: underline;"> </span></p>
</td>
<td width="110" valign="top">
<p><span style="text-decoration: underline;"> </span></p>
</td>
</tr>
<tr>
<td width="227" valign="top">
<p>b-2-microglobulin<span style="text-decoration: underline;"> </span></p>
</td>
<td width="79" valign="top">
<p>12<span style="text-decoration: underline;"> </span></p>
</td>
<td width="60" valign="top">
<p>5.8</p>
</td>
<td width="92" valign="top">
<p>30</p>
</td>
<td width="110" valign="top">
<p>96<span style="text-decoration: underline;"> </span></p>
</td>
</tr>
<tr>
<td width="227" valign="top">
<p>Elastase</p>
</td>
<td width="79" valign="top">
<p>34</p>
</td>
<td width="60" valign="top">
<p>10.6</p>
</td>
<td width="92" valign="top">
<p>30</p>
</td>
<td width="110" valign="top">
<p>0</p>
</td>
</tr>
<tr>
<td width="227" valign="top">
<p>a-1-antitrypsin</p>
</td>
<td width="79" valign="top">
<p>53</p>
</td>
<td width="60" valign="top">
<p>4.0</p>
</td>
<td width="92" valign="top">
<p>30</p>
</td>
<td width="110" valign="top">
<p>87</p>
</td>
</tr>
<tr>
<td width="227" valign="top">
<p>Lactoferrin</p>
</td>
<td width="79" valign="top">
<p>70</p>
</td>
<td width="60" valign="top">
<p>6.0</p>
</td>
<td width="92" valign="top">
<p>30</p>
</td>
<td width="110" valign="top">
<p>102</p>
</td>
</tr>
<tr>
<td width="227" valign="top">
<p>a-2-macroglobulin<span style="text-decoration: underline;"> </span></p>
</td>
<td width="79" valign="top">
<p>725<span style="text-decoration: underline;"> </span></p>
</td>
<td width="60" valign="top">
<p>5.4<span style="text-decoration: underline;"> </span></p>
</td>
<td width="92" valign="top">
<p>30</p>
</td>
<td width="110" valign="top">
<p>87</p>
</td>
</tr>
<tr>
<td width="227" valign="top">
<p>Total             serum protein<span style="text-decoration: underline;"> </span></p>
</td>
<td width="79" valign="top">
<p><span style="text-decoration: underline;"> </span></p>
</td>
<td width="60" valign="top">
<p><span style="text-decoration: underline;"> </span></p>
</td>
<td width="92" valign="top">
<p>30</p>
</td>
<td width="110" valign="top">
<p>95</p>
</td>
</tr>
<tr>
<td width="227" valign="top">
<p>Elastase             premixed with a-2-macroglobulin</p>
</td>
<td width="79" valign="top">
<p><br class="spacer_" /></p>
</td>
<td width="60" valign="top">
<p><br class="spacer_" /></p>
</td>
<td width="92" valign="top">
<p>10</p>
</td>
<td width="110" valign="top">
<p>74</p>
</td>
</tr>
</tbody>
</table>
<p>_______________________________________________________________</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;"> </span></p>
<p><span style="text-decoration: underline;">Paper VI</span></p>
<p><strong>Increased       release of free oxygen radicals from peripheral neutrophils in  adult       periodontitis after Fc-gamma receptor stimulation </strong></p>
<p><br class="spacer_" /></p>
<p>Neutrophils may  participate       in the tissue destruction in periodontitis by releasing oxygen  radicals       and proteases. Increased release of these agents has been  demonstrated in       juvenile periodontitis. Extracellular release of oxygen radicals  and       degranulation during in<em> vitro</em> activation of peripheral neutrophils was studied in 14 patients  with adult       periodontitis, nine men and five women (mean age 49.9 yrs.) and a  group of       age- and sex-matched healthy controls.</p>
<p>The peripheral neutrophils  were       purified, using a two-layer discontinuous Percoll gradient, washed  and       resuspended in PBS, pH 7.4, with 0.25% HSA. The peripheral  neutrophils       were activated with FcgR-stimulation        using IgG- opsonized <em>Staphylococcus       aureus </em>. The release of radicals during activation was  measured with       luminol-enhanced chemiluminescence. The light reaction was  followed until       a maximal light intensity was reached and was registered as  mV(peak).       Degranulation was assessed as the release of elastase (primary  granula)       and lactoferrin (secondary granula) after similar activation for  1h at +35°C.       Elastase was measured with a specific substrate and lactoferrin  with       ELISA. The study showed a 113% greater release of oxygen radicals  from       neutrophils <strong> </strong>in the       patients than in the healthy controls. The release of elastase was  also       elevated in the patients -the mean difference was 25%. However,  the       release of lactoferrin did not differ between the two groups  (Table 4).       The ratio of released elastase to lactoferrin was higher in the       periodontitis group. This is in accordance with our <em>in       vivo</em> findings in Paper III.</p>
<p><br class="spacer_" /></p>
<p>The present study  therefore       demonstrated that neutrophils from patients with adult  periodontitis had a       more marked reaction to Fc-receptor mediated activation even  before they       entered the inflammatory lesion. Whether this difference was due  to a       constitutional difference in the neutrophils <em>per       se</em> or to a priming of the circulating cells was not evaluated,  but it       indicates a neutrophil-associated specific host response.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p>_________________________________________________________________________________________</p>
<p>Table       2. Paper VI. Release of free oxygen radicals measured with       luminol-enhanced chemiluminescence (CL) (mean maximal light  intensity ±       SD), and cumulated release of elastase and lactoferrin during one  hour (mean       ± SD) after FcgR-stimulation.       The release was calculated in 106 neutrophil       granulocytes from 14 healthy controls (HC) and 14 patients with  adult       periodontitis (AP). The stimulation was performed with a  bacteria-to-cell       ratio of 300:1 and 75:1 for radical generation and degranulation,       respectively.</p>
<p>________________________________________________________________</p>
<p><br class="spacer_" /></p>
<table border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="137" valign="top">
<p><br class="spacer_" /></p>
</td>
<td width="92" valign="top">
<p>units</p>
</td>
<td width="155" valign="top">
<p>HC</p>
</td>
<td width="107" valign="top">
<p>AP</p>
</td>
<td width="125" valign="top">
<p>Difference              %</p>
</td>
<td colspan="5" width="580">
<p><br class="spacer_" /></p>
</td>
</tr>
<tr>
<td colspan="6" width="717" valign="top">
<p>_____________________________________________________________________________________</p>
</td>
<td width="92" valign="top">
<p><br class="spacer_" /></p>
</td>
<td width="155" valign="top">
<p><br class="spacer_" /></p>
</td>
<td width="107" valign="top">
<p><br class="spacer_" /></p>
</td>
<td width="125" valign="top">
<p><br class="spacer_" /></p>
</td>
</tr>
<tr>
<td width="137" valign="top">
<p>CL</p>
</td>
<td width="92" valign="top">
<p>mV             (peak)</p>
</td>
<td width="155" valign="top">
<p>1677 (±1111)</p>
</td>
<td width="107" valign="top">
<p>2756 (±1540)</p>
</td>
<td width="125" valign="top">
<p>+113.5</p>
</td>
<td colspan="5" width="580">
<p><br class="spacer_" /></p>
</td>
</tr>
<tr>
<td width="137" valign="top">
<p>Elastase</p>
</td>
<td width="92" valign="top">
<p>mAbs / h</p>
</td>
<td width="155" valign="top">
<p>4951 (±2711)</p>
</td>
<td width="107" valign="top">
<p>5440 (±1918)</p>
</td>
<td width="125" valign="top">
<p>+ 25.0</p>
</td>
<td colspan="5" width="580">
<p><br class="spacer_" /></p>
</td>
</tr>
<tr>
<td width="137" valign="top">
<p>Lactoferrin</p>
</td>
<td width="92" valign="top">
<p>ng / h</p>
</td>
<td width="155" valign="top">
<p>217             (±115)</p>
</td>
<td width="107" valign="top">
<p>180 (±66)</p>
</td>
<td width="125" valign="top">
<p>-  3.5</p>
</td>
<td colspan="5" width="580">
<p><br class="spacer_" /></p>
</td>
</tr>
<tr>
<td width="137" valign="top">
<p>Ratio             elastase/lactoferrin</p>
</td>
<td width="92" valign="top">
<p>arb.             u.</p>
</td>
<td width="155" valign="top">
<p>24.7             (±10.5)</p>
</td>
<td width="107" valign="top">
<p>31.6             (±10.5)</p>
</td>
<td width="125" valign="top">
<p>+ 51.0</p>
</td>
<td colspan="5" width="580">
<p><br class="spacer_" /></p>
</td>
</tr>
<tr height="0">
<td width="103"></td>
<td width="69"></td>
<td width="116"></td>
<td width="80"></td>
<td width="94"></td>
<td width="76"></td>
<td width="69"></td>
<td width="116"></td>
<td width="80"></td>
<td width="94"></td>
</tr>
</tbody>
</table>
<p>________________________________________________________________</p>
<p>The       difference (presented as the mean of 14 pairs) was calculated in  each pair       as follows: <span style="text-decoration: underline;">AP x 100</span> &#8211; 100 = %</p>
<p>HC</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>GENERAL DISCUSSION</strong></p>
<p><br class="spacer_" /></p>
<p>This thesis deals with  some       characteristics involved in the pathogenesis of the  tissue-destructive       inflammation in the gingiva -i.e., periodontitis &#8211; that leads to       degradation of the collagen fibres of the periodontal ligament.  The       accumulation of bacteria in the gingival crevice causes an  inflammatory       response which is tissue-destructive in about 5-10% of the  population.       This type of inflammation only seems to develop in some patients  and not       to be caused by specific periopathogens. Thus periodontitis is a       host-specific response to a comparatively normal bacterial  colonization of       the gingival sulcus. The tissue destruction appears to be  primarily       mediated by neutrophils.</p>
<p><br class="spacer_" /></p>
<p>In these studies, elastase  has been       used as a marker of neutrophil activation and degranulation of  primary       granule. Elastase is also able to cause tissue destruction  (Cergneux et       al. 1982). Elastase is released as active protease and degrades  most       extracellular matrix proteins, including collagen type I (Starkey  et al.       1977) -e.g., in Sharpey’s fibres. In Paper I the GCF analyses  showed       increased elastase activity, per site and per µL, in sites with       attachment loss and deep pockets of patients with periodontitis  (Fig. 1).</p>
<p>Elevated levels of  neutrophil       derived substances, such as b-glucuronidase        and elastase, have been reported by a number of investigators (see  Page       1992 and Lamster 1992, for review). Lamster recommends that  substances       found in GCF -e.g. elastase &#8211; should be calculated per site  because of the       risk of contamination with saliva, which can change the volume and       subsequently the concentration. However, the effect of such  contamination       can be markedly reduced by careful sampling techniques and by  discarding       the strips that may be contaminated (Griffiths et al. 1990). Deep  gingival       pockets contain larger volumes of GCF and probably have higher  amounts of       various substances. In Paper I a correlation was found between  elastase       activity per site and pocket depth. The measurements of GCF  content<strong> </strong>should therefore be calculated per µL in order to avoid the  influence       of larger volumes in deep pockets. The elastase activity per µL  was       higher in GCF from periodontitis sites than in GCF from gingivitis  sites       in subjects with gingivitis alone although the clinical signs of       inflammation (GI) were the same.  In       contrast, there was no difference in the amount of antigenic  elastase per       µL. This could be caused by a combination of higher release of  elastase       and an oxidative inactivation of a-1-antitrypsin        (A1AT) followed by a compensatory increased inhibition by a-2-macroglobulin       (A2MG). This  indicates that       the tissue destruction in periodontitis is associated with  hyperactive       neutrophils.<strong> </strong></p>
<p><br class="spacer_" /></p>
<p>Release       of oxygen radicals from neutrophils may oxidatively inactivate and  thus,       reduce the inhibitory capacity of the otherwise sufficient amounts  of A1AT       (Weiss 1989).  The impaired       inhibitory capacity of A1AT may, to some extent, be compensated  for by the       equally efficient and less oxidatively sensitive A2MG. This makes  it       important to study the relation of A2MG to increases in elastase  activity       in connection with inflammatory destruction.</p>
<p><br class="spacer_" /></p>
<p>In       Paper II, the local balance between A2MG and elastase was analysed  in the       same GCF sample from three types of sites (cf. Paper II in  Investigations       and Results). The amounts of this inhibitor per µL were  significantly       lower from sites with tissue destruction, while the elastase  activity per       µL was higher (Fig. 2). The findings of lower concentrations are  in       agreement with those of Skaleric et al. (1986). The most likely  mechanism       for reduced concentrations at the sites with destruction seems to  be       consumption of A2MG by free proteolytic activity        due to  the faster       clearance of the A2MG -protease complex than that of the native  A2MG. This       kinetic difference in elimination of A2MG has been demonstrated by  Debanne       (1975). The lower concentration of A2MG is therefore a secondary  sign of       proteolytic activity and, together with the higher elastase  activity,       strongly indicates the presence of a tissue-destructive  inflammatory       reaction, in agreement with Paper I.</p>
<p>However, in Paper II, the  two       variables elastase and A2MG could not distinguish between the two  types of       inflamed sites without attachment loss and without deep pockets in       patients with periodontitis and patients with gingivitis alone.  One       possible explanation is a difference in the number of neutrophils       accumulated in the lesion, although they had the same clinical  signs of       inflammation, as assessed by GI. However, GI is a rather  insensitive       measure of the degree of inflammation, expressed as the number of       neutrophils <strong> </strong>(Kowashi et al.  1980, Adonogianaki et al. 1993). It is       possible that the inflamed sites in the patients with gingivitis  alone, in       agreement with their higher GCF volumes (Paper II), in fact were  somewhat       more inflamed than the clinically similar sites in patients with       periodontitis. In consequence, the lesions of the gingivitis  patients may       have harboured more neutrophils, which increased the elastase  activity to       the levels of the sites in the periodontitis patients. However, if  it were       possible to establish the degree of inflammation, as regards the  amount of       neutrophils in the lesion, in the two types of gingivitis sites  rather       than by using the GI, the relation between proteolytic activity  and the       varying degrees of inflammation might reveal differences.</p>
<p>An increased release of  elastase       into the tissue and into the GCF must be caused either by an  increase in       the number of neutrophils and/or by an increase in the release of  this       substance from the neutrophils <em>per       se</em>.</p>
<p><br class="spacer_" /></p>
<p>In Paper III,  the elastase activity was related to the lactoferrin  content       in the same GCF sample in order to assess the release of elastase  in       relation to the number of neutrophils in the lesion.        Lactoferrin was chosen as a marker of neutrophils because  it is       specific for these cells (Benett &amp; Kokocinski 1978) and is  only found       in trace amounts in plasma (Hetherington et al. 1983). <em>In  vitro, </em>lactoferrin is released following chemotactic stimulation       (Bentwood &amp; Henson 1980) and it can be assumed that this  mainly occurs       during the migration from the blood vessel to the inflamed  gingival site.       Samples were obtained from the same three types of sites as in  Paper II.       The study showed a higher elastase activity per µL in the two  types of       sites in patients with periodontitis than in the sites in subjects  with       gingivitis alone.</p>
<p>In contrast, no difference  was noted       in the lactoferrin concentrations in the three types of sites  (Fig. 3). If       lactoferrin can be regarded as a marker of the number of  neutrophils, this       means that the “periodontitis neutrophils” released more elastase  per       cell, regardless of the pocket depth (PD, gingival inflammation  (GI), and       attachment level (CAL) at the sampled site. However, since the  substrate       used in this study is hydrolysed by the elastase-A2MG complex, an       alternative explanation is that a larger proportion of the  released       elastase is inhibited by A2MG instead of by A1AT. In any case,  both       interpretations indicate a neutrophil associated specific host  response in       periodontitis.</p>
<p><br class="spacer_" /></p>
<p>The analysis of the  protein       concentrations  (Paper IV) in       the same three types of sites as in the previous two studies  (Papers II       and III) showed a lower concentration in GCF samples from patients  with       periodontitis than in samples from gingivitis patients, which was  not       related to the clinical findings (PD, GI, CAL) in the sampled site  (Fig.       4). This study indicates that dilution of GCF may contribute to  the lower       concentration of A2MG in sites with attachment loss (Paper II).  However,       other mechanisms must be involved, since the low A2MG  concentration was        associated with attachment loss (Fig. 2) and not as the low  protein       concentration, found in all sites in patients with periodontitis.<strong> </strong>The physiological mechanism and the pathogenetic importance of  this       finding are not clear, but the result strongly supports the theory  of a       host specific response in periodontitis. <strong> </strong></p>
<p>Papers       I-III dealt with measurements of elastase in GCF that were made  with paper       strips. For this reason the sampling of GCF was evaluated in Paper  V.       Unlike elastase complexed with A2MG, pure elastase could not be  recovered       from the strips (Table 3). This means that the elastase measured  in the       previous GCF studies (Papers I-III) originates from this complex.       Moreover, it is unlikely that there is any free active elastase in  GCF,       since the calculated <em>in vivo</em> half-life of active elastase is 0.6 msec and, consequently, all  activity        should be inhibited after 3 msec (Travis &amp; Salvesen  1983). It       is not apparent why uncomplexed elastase cannot be eluated in  isotonic<strong> </strong>phosphate-buffered saline (pH 7.4). The molecular weight had  no       influence on the recovery, since the other proteins tested had a  recovery       of about 90 %, regardless of their molecular weight (12-725 kDa).  The fact       that elastase has a very high isoelectric point (IP) may provide  an       explanation, but an increase in the pH of the eluent did not  improve the       recovery.</p>
<p>In       conclusion, most proteins could be satisfactorily and reproducibly       recovered when the elution was made in isotonic buffer at neutral  pH and       without detergents to minimize lysis of the neutrophils. In  contrast, the       recovery of uncomplexed elastase was poor, showing that the  recoveries of       various proteins may differ. According to these findings, the  previous       investigations of GCF in this thesis, and in earlier studies made  with       paper strips and low-molecular elastase substrates, probably did  not       measure free elastase activity, but rather the activity of the       elastase-A2MG complex.</p>
<p>In       Paper III it was deducted that increased elastase activity in GCF  from       periodontitis patients could be due to an oxidative inactivation  of A1AT       with a subsequent increase in the need for inhibitory activity of  A2MG or       to an increased activity of the neutrophils <em>per       se</em>. Both explanations indicate an increase in the  neutrophil activity. It was therefore of interest to  study       the <em>in vitro </em>activation of       peripheral neutrophils. An increased release of oxygen radicals  (e.g., Åsman       et al. 1984,  Leino et al.       1994) and of elastase (Åsman 1988) has been reported in juvenile       periodontitis.</p>
<p><br class="spacer_" /></p>
<p>Fcg-receptor-mediated        activation of peripheral neutrophils (Paper VI) showed a doubling  of the       release of oxygen radicals from the neutrophils in a group of  adult       patients with periodontitis as compared to a group of healthy  controls       (Fig. 5). The release of oxygen radicals was measured with       luminol-enhanced chemiluminescence. In juvenile periodontitis, the       findings concerning <em>in vitro</em> release of oxygen radicals are inconclusive. Disagreement in the  results       are probably due to different activation mechanisms, such as  complement       factor activation (-e.g., opsonized zymosan), protein kinase C  (phorbol       myristate acetate) and activation by specific receptors (-e.g.,  Fc-gR).       However, investigators involving Fcg-receptor        activation with opsonized bacteria have consistently shown  increased CL       (Whyte et al. 1989, Shapira et al. 1991) in agreement with five  separate       studies in our laboratory (Åsman et al. 1984, 1986, 1988, Åsman  1988,        Åsman &amp; Bergström 1992).<strong> </strong>We also found a  higher       release of elastase, while the release of lactoferrin did not  differ       within the pairs. The ratio of elastase to lactoferrin release,  however,       was significantly higher in the patients with periodontitis, which  accords       with the finding in Paper III of a higher elastase/lactoferrin  ratio in       GCF from this type of patients.</p>
<p>Since       most studies using receptor mediated activation of the neutrophils  have       shown an increased release of oxygen radicals from neutrophils in       periodontitis patients, while studies using direct PKC activation  with PMA       have failed, it was reasonable to assume, that the difference is  to be       found at the level of the  receptors.       However, the higher activity was not associated with increased  number of       FcgIII-receptors       (CD16) on the cell membranes in Paper VI. This is in agreement  with       earlier findings in juvenile periodontitis (Åsman &amp; Bergström  1992,       Leino et al. 1994, Mouynet et al. 1995). Nor did the neutrophil       populations in the same study differ, regarding the expression of  the       adhesion molecules CD11a, b (LFA-1, Mac-1), CD15 (Lewis X), CD35  (CR1) and       CD62L (Mel-14/LECAM-1), between patients with periodontitis and       gingivitis.</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p>Taken       together, the studies in this thesis support the theory of a  specific host       response associated with hyperreactive neutrophils. Whether this       hyperreactivity of the neutrophils is a constitutional trait or is  due to       priming (an enhancement of the neutrophils’ ability to respond to       various stimuli) of the circulating cells is not known. Åsman et  al.       (1988) found that the increase in the release of oxygen radicals  from       neutrophils in patients with juvenile periodontitis persisted even  after       “successful” treatment. The view of a constitutional trait is       supported by a recent study by Pippin et al. (1995), that found  higher       intracellular content of b-glucuronidase        in neutrophils from patients with rapidly progressing  periodontitis. Other       investigators report that the neutrophil hyperreactivity in  juvenile       periodontitis is serum-associated (Agarwal et al. 1994, Shapira et  al.       1994), which would indicate a priming of the cells. Cytokines,  such as       tumor necrosis factor a (TNFa)       could be important primers of circulating neutrophils (Steinbeck  &amp;       Roth 1989). A priming by TNFa       has been suggested in association with adult respiratory distress  syndrome       (ARDS). ARDS is a very serious condition, usually seen in  connection with       severe injuries. It is  characterized       by rapid destruction of lung tissue, probably resulting from an  excessive       release of proteases from neutrophils in the lungs. Chollet-Martin  et al.       (1993) found higher plasma concentrations of TNFa       in patients suffering from ARDS than in patients with similar  injuries but       without ARDS. Neutrophils from patients with certain types of  obstructive       jaundice are less responsive to <em>in       vitro</em> priming with TNFa (Jiang  et       al.       1994). This could be due to an <em>in       vivo</em> priming that makes the cells less responsive to a second  priming <em>in       vitro</em> .</p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p><br class="spacer_" /></p>
<p>Some studies show impaired  or       altered chemotaxis of neutrophils in patients with localized  juvenile       periodontitis (-e.g., Clark et al. 1977, Van Dyke et al. 1982,  1990) and       in patients with refractory periodontitis (Oshrain et al. 1987).  This is       not necessarily in conflict with a higher extracellular release of  free       oxygen radicals, since a priming of the peripheral cells, besides       enhancing the oxidative metabolism, might also increase the  adherence of       the cells, and thereby impair their motility. In fact, there are  several       conditions with aberrant neutrophil functions that exhibit the  combination       of impaired chemotaxis and increased respiratory burst, such as  Down’s       syndrome, HIV and diabetes (cf. Introduction). Priming of human       neutrophils by tumor necrosis factor <em>in       vitro </em>has shown an enhanced release of oxygen radicals and       degranulation, and a simultaneous down-regulation of chemotaxis  (Bajaj et       al. 1992, Agarwal et al. 1994). It seems reasonable that future       pathogenetic studies of periodontitis should include evaluation of  a       possible influence of priming on the tissue-destructive activity  of the       neutrophils.</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><br class="spacer_" /></p>
</td>
<td width="6"></td>
</tr>
<tr>
<td width="22"></td>
<td width="624">
<p><strong>Conclusions </strong></p>
<p>The GCF studies (Papers  I-III) show       that patients with periodontitis have an increased neutrophil  elastase       activity, which is independent of pocket depth, fluid volume and  numbers       of neutrophils. This would suggest a relation between neutrophils  and a       host specific tissue-destructive type of inflammation. The <em>in vitro </em>study (Paper VI) shows an increased release of  oxygen       radicals and elastase from the neutrophils in periodontitis  patients. This       would imply that hyperactive neutrophils participate as effector  cells in       the tissue-destructive mechanism. The findings in this thesis  consistently       support the view that neutrophils play a major role in the  specific host       response in periodontitis.</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>ACKNOWLEDGEMENTS </strong></p>
<p><strong> </strong></p>
<p>I       wish to express my sincere gratitude to all of you who helped me  with this       study at the Centre for Clinical Oral Science, Department of       Periodontology and the  Department       of Medical Laboratory Sciences and Technology, Division of  Clinical       Chemistry, Karolinska Institutet, Huddinge Hospital, Huddinge,  Sweden. In       particular, I wish to thank:</p>
<p>Dr. Björn Åsman, tutor and  friend,       for never-failing enthusiasm and sincere interest in the daily  life of the       neutrophil. Without his encouragement, optimism and expertise  there would       have been no thesis.</p>
<p>Docent Kurt Bergström, my  tutor and       supervisor, for his constant support and for sharing with me his  vast       medical knowledge and scientific experience.</p>
<p>Professor Per-Östen Söder  for       introducing me to the field of scientific research and to  Bergström and       Åsman.</p>
<p>Docent Jan Bergström for  valuable       support and inspiring discussions about my research.</p>
<p>Dr Eva Åkerlöf for helping  me with       all my ELISA problems.</p>
<p>Laboratory engineer Göran  Nilsson       for continuous assistance in my laboratory work.</p>
<p>Gunvor Nilsson &amp;  Gunnel Zeisig       for their optimism, help and consideration.</p>
<p>Laboratory engineer  Hildegard       Sablica who gave me technical assistance and good advice.</p>
<p>Gun Nygren for her  excellent       assistance in the laboratory.</p>
<p>Leyla Gümüsay for  patiently       helping me with all those samples.</p>
<p>Francis and Zoe Walsh for  making my       English more readable, especially by introducing the comma.</p>
<p>My wife, Anita and my  boys, Erik and       Oskar, for their great patience, love and support.</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>REFERENCES </strong></p>
<p><strong> </strong></p>
<p>Adonogianaki E, Moughal J,  Kinane D       F. Lactoferrin in the gingival crevice as a marker of  polymorphonuclear       leucocytes in periodontal diseases. <em>J       Clin Periodontol </em>1993; <strong>20</strong>:       26-31</p>
<p>Agarwal S, Suzuki B,  Riccelli A E.       Role of cytokines in the modulation of neutrophil chemotaxis in  localized       juvenile periodontitis. <em>J Periodont       Res </em>1994; <strong>29</strong>: 127-137</p>
<p>Alfano M C. The origin of  gingival       fluid. <em>J theor Biol </em>1974; <strong>47</strong>:       127-136</p>
<p>Anderson R, Theron A J,  Ras G J.       Regulation by the antioxidants ascorbate, cysteine, and dapsone of  the       increased extracellular and intracellular generation of reactive  oxidants       by activated phagocytes from cigarette smokers. <em>Am       Rev Res Dis </em>1987; <strong>135</strong>:  1027-1032</p>
<p>Anderson R, Theron A J,  Richards G       A, Myer M S. Passive smoking by humans sensitizes circulating  neutrophils.       <em>Am Rev Res pirDis </em>1991; <strong>144</strong>:       570-574</p>
<p>Attström R. Studies on  neutrophil       polymorphonuclear leukocytes at the dento- gingival junction in  gingival       health and disease. <em>J Periodont Res </em>1971; <strong>6, Suppl 8</strong>: 6-15</p>
<p>Attström R, Egelberg J.  Emigration       of blood neutrophils and monocytes into the gingival crevices. <em>J Periodont Res </em>1970; <strong>5</strong>:       48-55</p>
<p>Baelum V, Fejederskov O,  Karring T.       Oral hygiene, gingivitis and periodontal breakdown in adult  Tanzanians. <em>J       Periodont Res </em>1986; <strong>21</strong>:       221-232</p>
<p>Baelum V, Fejederskov O,  Manji F.       Periodontal diseases in adult Kenyans.            <em>J Clin Periodontol </em>1988;  <strong>15</strong>:       445-452</p>
<p>Bajaj M S, Kew R R,  Webster R O,       Hyers T M. Priming of human neutrophil functions by tumor necrosis  factor:       enhancement of superoxide anion generation, degranulation, and  chemotaxis       to chemoattractants C5a and F-Met-Leu- Phe. <em>Inflammation </em>1992; <strong>16</strong>: 241-250</p>
<p>Barkin R M, Weston W L,  Humbert J R,       Maire F. Phagocytic function in Down syndrome &#8211; I Chemotaxis. <em>J ment Defic Res </em>1980; <strong>24</strong>:       243-249</p>
<p>Barkin R M, Weston W L,  Humbert J R,       Sudana K. Phagocytic function in Down syndrome &#8211; II Bactericidal  activity       and phagocytosis. <em>J ment Defic Res </em>1980; <strong>24</strong>: 251-256</p>
<p>Bazzoni F, Cassatella M A,  Rossi F,       Ceska M, Dewald B, Baggiolino M. Phagocytosing neutrophils produce  and       release high amounts of the neutrophil-activating peptide  1/interleukin 8.       <em>J Exp Med </em>1991; <strong>173</strong>: 771-774</p>
<p>Beck J D, Koch G G, Zambon  J J,       Genco R J, Tudor G E. Evaluation of oral bacteria as risk  indicators of       periodontitis in older adults. <em>J.       Periodontol </em>1992; <strong>63</strong>:  93-99</p>
<p>Benett R M, Kokocinski T.       Lactoferrin content of peripheral blood cells. <em>Brit       J Haematol </em>1978; <strong>39</strong>:  509-521</p>
<p>Bentwood B J, Henson P M.  The       sequential release of granule constituents from human neutrophils.  <em>J Immunol </em>1980; <strong>124</strong>:       855-862</p>
<p>Bergström J, Preber H.  Tobacco use       as a risk factor. <em>J Periodontol </em>1994; <strong>65</strong>: 545-550</p>
<p>Bergström K, Åsman B.  Luminol       enhanced Fc-receptor dependent chemiluminescence from peripheral  PMN       cells. A methodological study. <em>Scand       J Clin Lab Invest </em>1993; <strong>53</strong>:  171-177</p>
<p>Black G V. Phagedena  pericementi. <em>Ill       State Dental Soc </em>1882;       93-114</p>
<p>Bradford M M. A rapid and  sensitive       method for the quantitation of microgram quantities of protein,  utilizing       the principle of protein-dye binding. <em>Anal       Biochem </em>1976; <strong>72</strong>:  248-254</p>
<p>Cassatella M A. The  production of       cytokines by polymorphonuclear neutrophils. <em>Immunol       Today </em>1995; <strong>16</strong>: 21-26</p>
<p>Cergneux M, Andersen E,  Cimasoni G.       In vitro breakdown of gingival tissue by elastase from human       polymorphonuclear leukocytes. <em>J       Periodont Res </em>1982; <strong>17</strong>:  169-182</p>
<p>Chen C K C, Dunford R G,  Reynolds H       S, Zambon J J. <em>Eikenella corrodens</em> in the human oral cavity. <em>J       Periodontol </em>1989; <strong>60</strong>:  611-616</p>
<p>Chollet-Martin S,  Montravers P,       Gibert C, et al. Relationships between polymorphonuclear  neutrophils and       cytokines in patients with adult respiratory distress syndrome. <em>Ann N Y Acad Sci </em>1993;       354-366</p>
<p>Christersson L A, Albini  B, Zanbon J       J, Wikesjö U M E, Genco R S. Tissue localization of Actiobacillus       actinomycetemcomitans in human periodontitis. I Light,  immunofluorescence       and electron microscopic studies. <em>J       Periodontol </em>1987; <strong>58</strong>:       529-539</p>
<p>Cicco N A, Lindemann A,  Content J,       et al. Inducible production of interleukin-6 by human  polymorphonuclear       neutrophils: role of granulocyte-macrophage colony-stimulating  factor and       tumor necrosis factor-alpha. <em>Blood </em>1990; <strong>75</strong>: 2049-2052</p>
<p>Cimasoni G. Crevicular  fluid       updated. <em>Monographs in Oral Sience </em>1983,       2nd edition, <strong>12, </strong>Basel: Krager.</p>
<p>Clark R A, Page R C, Wilde  G.       Defective neutrophil chemotaxis in juvenile periodontitis. <em>Infect Immun </em>1977; <strong>18</strong>:       694-700</p>
<p>Compton S J, Jones C G.  Mechanism of       dye response and interference in the Bradford protein assay. <em>Anal Biochem </em>1985; <strong>151</strong>:       369-374</p>
<p>Curtis M A, Gillett I R,  Griffiths G       S, et al. Detection of high-risk groups and individuals for  periodontal       diseases: Laboratory markers from analysis of gingival crevicular  fluid.       1989; <strong>16</strong>: 1-11</p>
<p>Dahlén G, Manji G, Baelum  V,       Fejerskov O. Putative periopathogens in &#8220;diseased&#8221; and       &#8220;non-diseased&#8221; persons exhibiting poor oral hygiene. <em>J       Clin Periodontol </em>1992; <strong>19</strong>:       35-42</p>
<p>Debanne M T, Bell R,  Dolovich J.       Uptake of proteinase-a-macroglobulin        complexes by macrophages. <em>Biochim       Biophys Acta </em>1975; <strong>411</strong>:  295-304</p>
<p>Dewald B, Bretz U,  Baggiolini M.       Release of gelatinase from a novel secretory compartment of human       neutrophils. <em>J Clin Invest </em>1982;  <strong>70</strong>:       518-525</p>
<p>Dubravec D B, Spriggs D R,  Mannick J       A, Rodrick M L. Circulating human peripheral blood granulocytes  synthesize       and secrete tumor necrosis factor alpha. <em>Proc Natl Acad Sci USA </em>1990; <strong>87</strong>:       6758-6761</p>
<p>Dzink J L, Socransky S S,  Haffajee       AD. The predominant cultivable microbiota of active and inactive  lesions       of destructive periodontal diseases. <em>J       Clin Periodontol </em>1988; <strong>15</strong>:       316-323</p>
<p>Enwonwu C O. Cellular and  molecular       effect of malnutrition and their relevance to periodontal disease.  <em>J Clin Periodontol </em>1994;       <strong>21</strong>: 643-657</p>
<p>Ewetz L, Palmblad J, Thore  A. The       relationship between luminol chemiluminescence and killing of       Staphylococcus aureus by neutrophil granulocytes. <em>Blut </em>1981; <strong>43</strong>: 373-381</p>
<p>Faden H, Rossi T M.  Chemiluminescent       response of neutrophils from patients with inflammatory bowel  disease. <em>Dig       Dis Sci </em>1985; <strong>30</strong>:       139-142</p>
<p>Frank R M. Bacterial  penetration in       the apical pocket wall of advanced human periodontitis. <em>J Periodont Res </em>1980; <strong>15</strong>:       563-573</p>
<p>Gangbar S, Overall C M,  McCulloch C       A G, Sodek J. Identification of polymorphonuclear leukocyte  collagenase       and gelatinase activities in mouthrinse samples: Correlation with       periodontal disease activity in adult and juvenile periodontitis. <em>J Periodont Res </em>1990; <strong>25</strong>:       257-267</p>
<p>Giannopoulou C, Andersen  E,       Demeurisse C, Cimasoni G. Neutrophil elastase and its inhibitors  in human       gingival crevicular fluid during experimental gingivitis. <em>J       Dent Res </em>1992; <strong>71</strong>:  359-363</p>
<p>Green L W, Tryon W W,  Marks B, Huryn       J. Periodontal disease as a function of life-events stress. <em>J Stress </em>1986; <strong>12</strong>:       32-36</p>
<p>Griffiths G S, Curtis M A,  Wilton J       M A. Selection of a  filter paper with optimum properties for the       collection of gingival crevicular fluid. <em>J       Periodont Res </em>1988; <strong>23</strong>:  33-38</p>
<p>Griffiths G S, Wilton J M  A, Curtis       M A. Contamination of human gingival crevicular fluid by plaque  and       saliva. <em>Arch oral Biol </em>1992;  <strong>37</strong>:       559-564</p>
<p>Grossi S G, Zambon J J,  Norderyd C       M, et al. Microbiological risk indicators for periodontal disease.  <em>J Dent Res </em>1993; <strong>72</strong>:       206, abstr. 818</p>
<p>Haber J, Kent R L.  Cigarette smoking       in periodontal practice. <em>J       Periodontol </em>1992; <strong>63</strong>:  100-106</p>
<p>Haber J, Wattes J, Crowley  R.       Assessment of diabetes as a risk factor for periodontitis. <em>J Dent Res </em>1991; <strong>70</strong>:       abstr. 414</p>
<p>Haffajee A D, Socransky S  S, Smith       C, Dibart S. Relation of baseline microbial parameters to future       periodontal attachment loss. <em>J Clin       Periodont </em>1991; <strong>18</strong>:  744-750</p>
<p>Herrman F, Lindemann A,  Gauss J,       Mertelsmann R. Cytokine-stimulation of prostaglandin synthesis  from       endogenous and exogenous arachidonic acids in polymorphonuclear  leukocytes       involving activation and new synthesis of cyclooxygenase. <em>Eur J Immunol </em>1990; <strong>20</strong>:       2513-2516</p>
<p>Hetherington S V,  Spitznagel J K,       Quie P G. An enzyme-linked immunoassay (ELISA) for measurement of       lactoferrin. <em>J Immunol Met </em>1983;  <strong>65</strong>:       183-190</p>
<p>Hinrichs J E, Bandt C L,  Smith J A,       Golub L M. A comparison of 3 systems for quantifying gingival  crevicular       fluid with respect to linearity and the effect of qualitative  differences       in fluids. <em>J Clin Periodontol </em>1984;  <strong>11</strong>:       652-661</p>
<p>Holdsworth S R, Bellomo R.       Differential effect of steroids on leukocyte-mediated  glomerulonephritis. <em>Kidney       Int </em>1984; <strong>26</strong>:       162-169</p>
<p>Holm G. Smoking as an  additional       risk for tooth loss. <em>J Periodontol </em>1994; <strong>65</strong>: 996-1001</p>
<p>Hugosson A, Laurell l,  Lundgren D.       Frequency distribution of individuals aged 20-70 years according  to       severity of periodontal experience in 1973 and 1983. <em>J       Clin Periodontol </em>1992; <strong>19</strong>:       227-232</p>
<p>Ingman T, Sorsa T,  Michaelis J,       Konttinen Y T. Immunohistochemical study of neutrophil- and       fibroblast-type collagenase and stromelysin-1 in adult  periodontitis. <em>Scand       J Dent Res </em>1994; <strong>102</strong>:       342-349</p>
<p>Jack R M, Fearon D T.  Selective       synthesis of mRNA and proteins by human peripheral blood  neutrophils. <em>J Immunol </em>1988; <strong>140</strong>:       4286-4293</p>
<p>Janoff A. Biochemical  links beween       cigarette smoking and emphysema. <em>J       Appl Physiol </em>1983; <strong>55</strong>:  285-293</p>
<p>Janoff A. Elastase in  tissue injury.       <em>Ann Rev Med </em>1985; <strong>36</strong>: 207-216</p>
<p>Jiang W G, Puntis M C A,  Hallett M       B. Neutrophil priming by cytokines in patients with obstructive  jaundice. <em>HPB       Surg </em>1994; <strong>7</strong>:       281-289</p>
<p>Kenney E B, Kraal J H,  Saxe S R,       Jones J. The effect of cigarette smoke on human oral  polymorphonuclear       leukocytes. <em>J Periodont Res </em>1977;  <strong>12</strong>:       227-234</p>
<p>Kharazmi A, Rechnitzer C,  Schiøtz P       O, Jensen T, Baek L, Høiby N. Priming of neutrophils for enhanced       oxidative burst by sputum from cystic fibrosis patients with <em>Pseudomonas       aeruginosa</em> infection. <em>Eur J Clin       Invest </em>1987; <strong>17</strong>:  256-261</p>
<p>Kowashi Y, Jaccard F,  Cimasoni G.       Increase of free collagenase and neutral protease activities in  the       gingival crevice during experimental gingivitis in man. 1979; <strong>24</strong>:       645-650</p>
<p>Kowashi Y, Jaccard F,  Cimasoni G.       Sulcular polymorphonuclear leukocytes and gingival exudate during       experimental gingivitis in man. <em>J       Periodont Res </em>1980; <strong>15</strong>:  151-158</p>
<p>Kraal J H, Kenney E B. The  response       of polymorphonuclear leukocytes to chemotactic stimulation for  smokers and       non-smokers. <em>J Periodont Res </em>1979; <strong>14</strong>: 383-389</p>
<p>Kretschmer R R,  Lopez-Osuna M, De la       Rosa L , Armendares S. Leukocyte function in Down&#8217;s syndrome  quantitative       N.B.T. reduction and bactericidal capacity. <em>Clin       Immunol Immunopath </em>1974; <strong>2</strong>:       449-455</p>
<p>LaFleur M, Beaulieu A D,  Kreis C,       Poubelle P. Fibronectin gene expression in polymorphonuclear  leukocytes. <em>J       Biol Chem </em>1987; <strong>262</strong>:       2111-2115</p>
<p>Lamster I B. The host  response in       gingival crevicular fluid: Potential applications in periodontitis       clinical trials. <em>J Periodontol </em>1992;  <strong>63</strong>:       1117-1123</p>
<p>Lavstedt S, Eklund G. Some  factors       of significance for proximal marginal bone loss studied on an       epidemiological material. <em>Acta Odontol Scand </em>1975;       <strong>33</strong>: 50-89</p>
<p>Lavstedt S, Eklund G,  Henrikson C-O.       Partial recording in conjunction with roentgenologic assessment of       proximal marginal bone loss. <em>Acta Odontol Scand </em>1975;       <strong>33</strong>: 90-113</p>
<p>Lehner T. Cell-mediated  immune       responses in oral disease: A review. <em>J       oral    Path </em>1972; <strong>1</strong>: 39-58</p>
<p>Leino L, Hurttia H M,  Sorvajärvi K,       Sewom L A. Increased respiratory burst activity is associated with  normal       expression of IgG-Fc-receptors and complement receptors in  peripheral       neutrophils from patients with juvenile periodontitis. <em>J       Periodont Res </em>1994; <strong>29</strong>:       179-184</p>
<p>Liljenberg B, Lindhe J,  Berglundh T,       Dahlén G, Jonsson R. Some microbiological, histopathological and       immunohistochemical characteristics of progressive periodontal  disease. <em>J Clin Periodontol </em>1994;       <strong>21</strong>: 720-727</p>
<p>Lindemann A, Riedel D,  Oster W,       Ziegler-Heitbrock H W, Mertelsmann R, Herrmann F.  Granulocyte-macrophage       colony-stimulation factor induces cytokine secretion by human       polymorphonuclear leukocytes. <em>J Clin       Invest </em>1989; <strong>83</strong>:  1308-1312</p>
<p>Lindhe J, Haffajee A D,  Socransky S       S. Progression of periodontal disease in adult subjects in the  absence of       periodontal therapy. <em>J Clin       Periodontol </em>1983; <strong>10</strong>:       433-442</p>
<p>Lloyd A R, Oppenheim J J.  Poly&#8217;s       lament: the neglected role of the polymorphonuclear neutrophil in  the       afferent limb of the immune response. <em>Immunol       Today </em>1992; <strong>13</strong>: 169-172</p>
<p>Löe H. The gingival index,  the       plaque index and the retention index system.            <em>J Periodont Res </em>1967;  <strong>38</strong>:610-616</p>
<p>MacFarlane G D, Herzberg M  C, Wolff       L F, Hardie N A. Refractory periodontitis associated with abnormal       polymorphonuclear leukocyte phagocytosis and cigarette smoking. <em>J Periodontol </em>1992; <strong>63</strong>:       908-913</p>
<p>MacFarlane T W, Jenkins W M  M,       Gilmour W H, McCourtie J, McKenzie D. Longitudinal study of  untreated       periodontitis (II). Microbiological findings. <em>J       Clin Periodontol </em>1988; <strong>15</strong>:       331-337</p>
<p>Magnusson I, Low S B,  McArthur W P,       et al. Treatment of subjects with refractory periodontal disease. <em>J Clin Periodontol </em>1994;       <strong>21</strong>: 628-637</p>
<p>Manouchehr-puor M,  Spagnuolo P J,       Rodman H M, Bissada N F. Comparison of neutrophil chemotactic  response in       diabetic patients with mild and severe periodontal disease. <em>J       Periodontol </em>1981; <strong>52</strong>:       410-414</p>
<p>Marucha P T, Zeff R A,  Kreutzer D L.       Cytokine regulation of IL-1b gene       expression in the human polymorphonuclear leukocyte. <em>J       Immunol </em>1990; <strong>145</strong>:  2932-2937</p>
<p>McMullen J A, Dyke T E V,       Horoszewicz H U, Genco R J. Neutrophil chemotaxis in individuals  with       advanced periodontal disease and a genetic predisposition to  diabetes. <em>J Periodontol </em>1981; <strong>52</strong>:       167-173</p>
<p>McNamara M P, Weissner J  H,       Collins-Lech C, Hahn B L, Sohnle P G. Neutrophil death as a  defense       mechanism against <em>Candida albicans</em>.       <em>Lancet </em>1988; <strong>II(8621)</strong>:       1163-1165</p>
<p>Meyle J. Leukocyte  adhesion       deficeiency and prepubertal periodontitis. <em>Periodontology        2000 </em>1994; <strong>6</strong>: 26-36</p>
<p>Michalowicz B S, Aeppli D,  Virag J       G, et al. Periodontal finding in adult twins. <em>J       Periodontol </em>1991; <strong>62</strong>:       293-299</p>
<p>Miller D R, Lamster I B,  Chasens A       I. Role of the polymorphonuclear leukocyte in periodontal health  and       disease. <em>J Clin Periodontol </em>1984;  <strong>11</strong>: 1-15</p>
<p>Modéer T, Barr M, Dahllöf  G.       Periodontal disease in children with Down&#8217;s syndrome. <em>Scand        J Dent Res </em>1990; <strong>98</strong>:       228-234</p>
<p>Moore W E C, Moore L H,  Ranney R R,       Smibert R M, Burmeister J A, Schenkein H A. The microflora of  periodontal       sites showing active destructive progression. <em>J       Clin Periodontol </em>1991; <strong>18</strong>:       729-739</p>
<p>Mouynet P, Picot C,  Nicolas P, et       al. Ex vivo studies of polymorphonuclear neutrophils from patients  with       early-onset forms of periodontitis</p>
<p>(III) CR3 and LFA-1  expression by       peripheral blood and crevicular polymorphonuclear neutrophils. <em>J Clin Periodontol </em>1995;       <strong>22</strong>: in print</p>
<p>Murray P A. Periodontal  diseases in       patients infected by human immunodeficiency virus. <em>Periodontology        2000 </em>1994; <strong>6</strong>: 50-67</p>
<p>Murray P A, Grassi M,  Winkler J R.       The microbiology of HIV-associated periodontal lesions. <em>J Clin Periodontol </em>1989;       <strong>16</strong>: 636-642</p>
<p>Nurcombe H L, Bucknall R  C, Edwards       S W. Neutrophils isolated from the synovial fluid of patients with       rheumatoid arthritis:priming and activation in vivo. <em>Ann        Rheum Dis </em>1991; <strong>50</strong>:       147-153</p>
<p>Offenbacher S, Soskolne W  A, Collins       J G. Prostaglandin and other eicosanoids in gingival crevicular  fluid as       markers of periodontal disease susceptibility and activity. In:  Johnson       NW, ed <em>Risk markers for oral       disease, </em>Vol. 3. Periodontal diseases:        markers of disease susceptibility and activity. London CUP,  1991; 313-337</p>
<p>Oshrain H I, Telsey B,  Mandel I D.       Neutrophil chemotaxis in refractory cases of periodontitis. <em>J Clin Periodontol </em>1986;       <strong>14</strong>: 52-55</p>
<p>Overall C M, Sodek J,  McCulloch C A       G, Birek P. Evidence for polymorphonuclear leukocyte collagenase  and       92-kilodalton gelatinase in gingival crevicular fluid. <em>Infect        Immun </em>1991; <strong>59</strong>:  4687-4692</p>
<p>Page R C, Schroeder H E.       Pathogenisis of inflammatory periodontal disease. <em>Lab       Invest </em>1976; <strong>33</strong>:  235-249</p>
<p>Page R C. Host response  tests for       diagnosing periodontal diseases.                              <em>J Periodontol </em>1992; <strong>63</strong>: 356-366</p>
<p>Pippin D J , Cobb C M,  Feil P.       Increased interacellular levels of lysosomal b-glucuronidase       in peripheral blood PMNs from humans with rapidly progressive       periodontitis. <em>J Periodont Res</em> 1995; <strong>30</strong>: 42-50</p>
<p>Preber H, Bergström J. The  effect       of nonsurgical treatment on periodontal pockets in smokers and  nonsmokers.       <em>J Clin Periodontol </em>1985; <strong>13</strong>:       319-323</p>
<p>Preber H, Bergström J.  Effect of       cigarette smoking on periodontal healing following surgical  therapy. <em>J Clin Periodontol </em>1990;       <strong>17</strong>: 324-328</p>
<p>Preber H, Bergström J,  Linder L.       Occurrence of periopathogens in smoker and nonsmoker patients. <em>J Clin Periodontol </em>1992;       <strong>19</strong>: 667-671</p>
<p>Reuland-Bosma W, Dijk J v.       Periodontal disease in Down&#8217;s symdrome: a review. <em>J       Clin Periodontol </em>1986; <strong>13</strong>:       64-73</p>
<p>Rivkind A I, Siegel J H,  Littleton       M, et al. Neutrophil oxidative burst activation and pattern of  respiratory       physiologic abnormalities in the fulminate post-traumatic adult       respiratory distress syndrome. <em>Circ       Shock </em>1991; <strong>33</strong>: 48-62</p>
<p>Rowe G T, Eaton L R, Hess M  L.       Neutrophil-derived, oxygen-free radical-mediated cardiovascular       dysfunction. <em>J Mol Cell Cardiol </em>1984;  <strong>16</strong>:       1075-1079</p>
<p>Ryder M I, Winkler J R,  Weinreb R N.       Elevated phagocytosis, oxidative burst, and F-actin formation in  PMNs from       individuals with intraoral manifestations of HIV infection. <em>J Acquir Immune Defic Syndr </em>1988;       <strong>1</strong>: 346-353</p>
<p>Saari H, Suomalainen K,  Lindy O,       Konttinen Y T, Sorsa T. Activation of latent neutrophil  collagenase by       reactive oxygen species and serine protease. <em>Biochem       Biophys Res Com </em>1990; <strong>171</strong>:       979-987</p>
<p>Schenkein A, Genco R J.  Gingival       fluid and serum in periodontal diseases.</p>
<p>I. Quantitative study of immunoglobulins, complement  components and       other plasma proteins. <em>J Periodontol </em>1977; <strong>48</strong>: 772-777</p>
<p>Schenkein H A, Genco R J.  Gingival       fluid and serum in periodontal diseases. II Evidence for cleavage  of       complement components C3, C3 proactivator (factor B) and C4 in  gingival       fluid. <em>J Peridontol </em>1977;  778-784</p>
<p>Seymour G J, Whyte G J,  Powell R N.       Chemiluminescence in the assessment of polymorphonuclear leukocyte       function in chronic inflammatory periodontal disease. <em>J       Oral Pathol </em>1986; <strong>15</strong>:       125-131</p>
<p>Shapira L, Borinski R,  Sela M N,       Soskolne A. Superoxide formation and chemiluminescence of  peripheral       polymorphonuclear leukocytes in rapidly progressive periodontitis.  <em>J Clin Periodontol </em>1991;       <strong>18</strong>: 44-48</p>
<p>Shapira L, Gordon B,  Warbington M,       Van Dyke T E . Priming effect of <em>Porphyromonas       gingivalis</em> lipopolysaccharide on superoxide production by  neutrophils       from healthy and rapidly progressive periodontitis subjects.                <em>J Periodontol </em>1994; <strong>65</strong>: 129-131</p>
<p>Shirafuji N, Matsuda H,  Ogura K, et       al. Granulocyte colony-stimulating factor stimulates human mature       neutrophilic granulocytes to produce interferon-alpha. <em>Blood </em>1990; <strong>75</strong>: 17-19</p>
<p>Silness J, Löe H.  Periodontal       disease in pregnancy. II. Correlation between oral hygiene and  periodontal       condition. <em>Acta  Odontol Scand </em>1964;  <strong>22</strong>: 121-131</p>
<p>Sisson J H, Prescott S M,  McIntyre T       M, Zimmerman G A. Production of platelet-activating factor by  stimulated       human polymorphonuclear leukocytes. <em>J       Immunol </em>1987; <strong>138</strong>:  3918-3926</p>
<p>Socransky S S. Relation of  counts of       microbial species to clinical status at the sampled site. <em>J Clin Periodontol </em>1991;       <strong>18</strong>: 766-775</p>
<p>Socransky S S, Haffajee A  D, Goodson       J M, Lindhe J. New concepts of destructive periodontal disease. <em>J Clin Periodontol </em>1984;       <strong>11</strong>: 21-32</p>
<p>Springer T A. Traffic  signals for       lymphocyte recirculation and leukocyte emigration: the multistep  paradigm.       <em>Cell </em>1994; <strong>76</strong>: 301-314</p>
<p>Starkey P M, Barrett A J,  Burleigh P       M. Degradation of articular collagen by neutrophil proteinases. <em>Biochim       Biophys Acta </em>1977; <strong>483</strong>:  386-397</p>
<p>Steinbeck M J, Roth J A.  Neutrophil       activation by recombinant cytokines. <em>Rev       Infect Dis </em>1989; <strong>11</strong>:       549-568</p>
<p>Stendahl O, Coble B-I,  Dahlgren C,       et al. Myeloperoxidase modulates the phagocytic activity of       polymorphonuclear neutrophil leukocytes. Studies with cells from a       myeloperoxidase-deficient patient. <em>J       Clin Invest </em>1984; <strong>73</strong>:       366-373</p>
<p>Tanaka H, Ogura H,       Yokota J,et al. Acceleration of superoxide       production from leukocytes in trauma patients. <em>Ann       Surg </em>1991; <strong>214</strong>: 187-192</p>
<p>Tanaka H, Shimazu T,  Sugimoto H, et       al. A sensitive and specific assay for granulocyte elastase in       inflammatory tissue fluid using       L-pyroglutamyl-L-propyl-L-valine-p-nitroanilide. <em>Clin       Chim Acta </em>1990; <strong>187</strong>:       173-180</p>
<p>Travis J, Salvesen G S.  Human plasma       proteinase inhibitors. <em>Annu Rev       Biochem </em>1983; <strong>52</strong>:  655-709</p>
<p>Tuma S N, Martin R R,  Mallette L E,       Eknoyan G. Augmented polymorphonuclear chemiluminescence in  patients with       secondary hyperparathyroidism. <em>J Lab       Clin Med </em>1981; 291-298</p>
<p>Ulich T R, Guo K, Yin S,  et al.       Endotoxin-induced cytokine gene expression in vivo. IV. Expression  of       interleukin-1 alpha/beta and interleukin-1 receptor antagonist  mRNA during       endotoxemia and during endotoxin-initiated local acute  inflammation. <em>Am       J Path </em>1992; <strong>141</strong>:       61-68</p>
<p>VanDyke T E, Levine M J,  Genco R J.       Neutrophil function and oral disease. 1983; <strong>14</strong>:  95-120</p>
<p>VanDyke T E, Levine M J,  Al-Hashimi       I, Genco R J. Periodontal diseases and impaired neutrophil  function. <em>J       Periodont Res </em>1982; <strong>17</strong>:       492-494</p>
<p>VanDyke T E, Warbington M,  Gradner       M, Offenbacher S. Neutrophil surface protein markers as indicators  of       defective chemotaxis in LPJ. <em>J Periodontol </em>1990; <strong>61</strong>:       180-184</p>
<p>Velden U v       d, Abbas F, Armand S, et al. The effect of  sibling       relationship on the periodontal condition. <em>J       Clin Periodontol </em>1990; <strong>20</strong>:       683-690</p>
<p>Weiss S J. Tissue  destruction by       neutrophils. <em>N Engl J Med </em>1989; <strong>320</strong>:       365-376</p>
<p>Wewers M D, Herzyk D J,  Gadek J E.       Alveolar fluid neutrophil elastase activity in the adult  respiratory       distress syndrome is complexed to alpha-2-macroglobulin. <em>J       Clin Invest </em>1988; <strong>82</strong>:       1260-1267</p>
<p>Whyte G J, Seymour G J,  Cheung K,       Robison M F. Chemiluminescence of peripheral polymorphonuclear  leukocytes       from adult periodontitis patients. <em>J       Clin Periodontol </em>1989; <strong>16</strong>:       69-74</p>
<p>Williams R C, Jeffcoat M  K, Howell T       H, et al. Altering the progression of human alveolar bone loss  with the       non-steroidal antiinflammatory drug flurbiprofen. <em>J       Periodontol </em>1989; <strong>60</strong>:       485-490</p>
<p>Wilton J M A, Griffiths G  S, Curtis       M A, et al. Detection of high-risk groups and individuals for  periodontal       disease. Systemic predisposition and markers of general health. <em>J Clin Periodontol </em>1988;       <strong>15</strong>: 399-346</p>
<p>Wolff L F, Aeppli D M,  Pihlstrom B,       et al. Natural distribution of 5 bacteria associated with  periodontal       disease. <em>J Clin Periodontol </em>1993;  <strong>20</strong>:       699-706</p>
<p>Wright D G. Human  neutrophil       degranulation. <em>Meth Enzymol </em>1988;  <strong>162</strong>:       538-551</p>
<p>Wright D G, Gallin J I.  Secretory       responses of human neutrophils: Exocytosis of specific (secondary)       granules by human neutrophils during adherence <em>in       vitro </em> and during       exudation <em>in vivo</em>. <em>J Immunol </em>1979; <strong>123</strong>: 285-294</p>
<p>Yalda B, Offenbacher S,  Collins J G.       Diabetes as a modifier of periodontal disease expression. <em>Periodontology 2000 </em>1994;       <strong>6</strong>: 37-49</p>
<p>Yoneyama T, Okamoto H,  Lindhe J,       Socransky S S, Haffajee A D. Probing depth, attachmentloss and  gingival       recession. <em>J Clin Periodontol </em>1988;  <strong>15</strong>:       581-591</p>
<p>Åsman B. Peripheral PMN  cells in       juvenile periodontitis: Increased release of elastase and of  oxygen       radicals after stimulation with opsonized bacteria.           <em>J Clin Periodontol </em>1988;  <strong>15</strong>:       360-364</p>
<p>Åsman B, Bergström K,  Wijkander P,       Lockowandt B. Influence of plasma components on luminol-enhanced       chemiluminescence from peripheral granulocytes in juvenile  periodontitis. <em>J Clin Periodontol </em>1986;        <strong>13</strong>: 850-855</p>
<p>Åsman B, Bergström K,  Wijkander P,       Lockowandt B. Peripheral PMN cell activity in relation to  treatment of       juvenile periodontitis. <em>Scand J Den       Res </em>1988; <strong>96</strong>: 418-420</p>
<p>Åsman B, Bergström K.  Expression       of Fc-g-RIII       and fibronectin in peripheral polymorphonuclear neutrophils with  increased       response to Fc stimulation in patients with juvenile  periodontitis. <em>Archs       oral Biol </em>1992; <strong>37</strong>:       991-995</p>
<p>Åsman B, Ekberg O, Hjerpe  A.       Collagen degradation by experimentally-induced subcutaneous  granulation       tissue in the rat. <em>Archs oral Biol </em>1988; <strong>33</strong>: 65-70</p>
<p>Åsman B, Engström P-E,  Olsson T,       Bergström K. Increased luminol-enhanced chemiluminescence from  peripheral       granulocytes in juvenile periodontitis. <em>Scand       J Dent Res </em>1984; <strong>92</strong>:  218-223</p>
<p><br class="spacer_" /></p>
</td>
<td width="6"></td>
</tr>
</tbody>
</table>
]]></content:encoded>
			<wfw:commentRss>http://www.periodontiamedica.com.br/function-of-neutrophilic-granulocytes-in-periodontitis-a-pathogenetic-study-of-a-tissue-destructive-inflammation-by-anders-gustafsson/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hyperreactive Neutrophyls – A Mechanism of tissue destruction in Periodontitis</title>
		<link>http://www.periodontiamedica.com.br/hyperreactive-neutrophyls-%e2%80%93-a-mechanism-of-tissue-destruction-in-periodontitis/</link>
		<comments>http://www.periodontiamedica.com.br/hyperreactive-neutrophyls-%e2%80%93-a-mechanism-of-tissue-destruction-in-periodontitis/#comments</comments>
		<pubDate>Mon, 15 Mar 2010 00:56:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Teses]]></category>

		<guid isPermaLink="false">http://www.periodontiamedica.com.br/?p=114</guid>
		<description><![CDATA[I– PREFACE
 This thesis is basesd on the following articles, which will be referred to in the text by Roman numerals:
I– Protease activity in gingival crevicular fluid. Presence of three protease. Figueredo CMS &#38; Gustafsson A. Journal of clinical Periodontology 1998:25; 306 –310.
II– Activity and inhibition of elastase in GCF.
 Figueredo CMS &#38; Gustafsson A. [...]]]></description>
			<content:encoded><![CDATA[<p>I– PREFACE<br />
 This thesis is basesd on the following articles, which will be referred to in the text by Roman numerals:</p>
<p>I– Protease activity in gingival crevicular fluid. Presence of three protease. Figueredo CMS &amp; Gustafsson A. Journal of clinical Periodontology 1998:25; 306 –310.</p>
<p>II– Activity and inhibition of elastase in GCF.<br />
 Figueredo CMS &amp; Gustafsson A. Journal of clinical Periodontology 1998:25; 531 –535.</p>
<p>III– Increased release of elastase from in vitro activated peripheral neutrophilis in patients with adult periodontitis. Figueredo CMS, &amp; Gustafsson A, Asman B and Bergström K. Journal of clinical Periodontology 1999:26; 206 –211.</p>
<p>IV– Increased interleukin–1ß concentration in GCF as a characteristic tarit of patients with periodontitis. Figueredo CMS, Ribeiro MSM, Fischer RG, and Gustafsson A. Journal of Periodontology; resubmitted for publication in February 1999.</p>
<p>V– Increased amounts of laminin in GCF from untreated patients with periodontitis.<br />
 Figueredo CMS, &amp; Gustafsson A. Journal of Clinical Periodontology; submitted for publication in March 1999.</p>
<p>II– Introduction 1</p>
<p>Periodontitis</p>
<p>A crevicular accumulation of microbes, follewed by inflammation and immune reaction, are the main features of gingivitis and periodontitis. A small but definite infiltrate of inflammatory cells can be detected in the coronal portion of the connective tissue, although the clinical findings are not typical of inflammation. Thus, a subclinical inflammatory reaction is generally present in clinically healthy gingiva (Page &amp; Schroeder 1976).</p>
<p>Plaque accumulation in the crevice leads to an increase in the inflammatory reaction that can be seeen clinically and microscopically. Until a gengival lesion becomes &#8220;established&#8221; (Page &amp; Schroeder 1976), this pattern persists, with inflammation following plaque accumulation. At a certain stage in this process, marked irreversible tissue destruction begins. Degradation of the connective tissue is followed by junctional epithelial migration and bone resorption. This stage is at the border line between gingivitis and periodontitis. It is not clear why some lesions remain localized on the marginal part of the gingival tissues, while others go on to loss of connective tissue attachment and supporting alveolar bone. Moreover the severity of periodontal tissue damage often varies from tooth to tooth and even from surface on the same tooth in the same subject.</p>
<p>Epidemiological studies show that the frequency of the severe form of adult periodontitis is very low in the population. The percentage of subjects with the disease tends to increase with age, reaching a peak at 50–60 years. Brown et al. (1989) reported that only 3.4% of the United States population between 19–44 years had 1 or more pockets deeper than 6 mm. This percentage increased to 16.5% in the population between 45–64 yeras, and decreased to 14 % in those 65 years or more.</p>
<p>Baelum et al. (1986) studied adult tanzanians aged 30–69 years, having large amounts of plaque and caculus, and found that only 19% showed pockets deeper than 3 mm and attachment loss &gt; 6mm. Seventy–five percent of the tooth sites with attachment loss 7 mm were found in 31% of the subjects, showing that advanced periodontal disease does not correlate with supragingival plaque levels. The same investigators (Baelum et al.1988) observed, in a 15 to 65 year old population in Kenya where poor oral hygiene was reflected by plaque, calculus and gingivitis, that pockets 4 mm deep were found on less than 20% of the surfaces, and the proportion oof sites per subject with deep pockets and advancedloss of attachment showed a markedly skewed distribuition.</p>
<p>The current view of the role of micro–organisms as the principal etiologic factor in periodontal diseases can be summarized by saying that the periodontopathic bacterial flora is &#8220;necessary, but not sufficient to cause disease&#8221; or that periodontal disease are&#8221; specific mixed infections which cause periodontal destruction in an appropriately host&#8221; (Offenbacher 1996). This renewed emphasis on the host–response in pathoogenesis is based on three factors: (1) the inflammataryresponse varies greatly from one subject to another (Movig et al. 1988, Pociot et al. 1992, Shapira et al. 1994). (2) epidemiological population studies show that microbial parameters account for only some of the incidence and prevalence of the disease. Other factors, such as smoking, stress, systemic diseases, genetic and biochemical markers of inflammation, also contributesignificantly to multivariate models of disease expression, independently of the microbial infections (Beck at al. 1990; Beck et al. 1992; Christersson et al. 1992; Eheeler et al. 1994). (3)Epidemiologic studies in twins have suggested that, overall, about half the variability of periodontal disease expression is controlledby genetic, not microbial, factors (Michalowicz 1993; 1994).</p>
<p>Wolff et al. (1993) found that the frequency and levels of five gram–negative anaerobic bacteria, P. gingivalis, A. actinomycetemcomitans, P. intermidia, E. corrodens and F. nucleatum, correlated with the probing depth of 6905 sites sampled. This could be either an indicator of disease or simply the result of a more favourable environment. Deep pockets favour anaerobic bacteria, such as those mentioned above but they can also be found in shallow pockets, even in subjects without periodontitis (chen et al. 1989; Dahén et al. 1992). According to Wolff et al. (1993) the finding that periopathogens frequently inhabit sites not associated with advanced disease suggests that a susceptible host is necessary.</p>
<p>Although reports on the presence of still unidentified etiologic organisms or pathogenic clonal types cannot be disregarded, it is not correct to say that specific organisms are the cause of severe disease. According to Kornman &amp; di Giovine (1998), the response to chronic inflammation may be modified by factors that do not directly cause the disease, but modify some aspects of it to aggravate the clinical conditions. The chronic reaction of an inflammation may be disproportionated to the pathogenic challenge, resulting in a response detrimental to the host. Smoking (Harber 1994), diabetes (Salvi et al. 1997c) and genetic influences (Kornman et al. 1997) may place some subjects at relatively high risk for an increase in the severity of periodontitis.</p>
<p>1.1– Risk factors</p>
<p>A risk factor is part of the causal chain of a particular disease or can lead to exposure of the host toa a disease (Beck 1994). The presence of a risk factor implies a direct increase in the probability of that a disease will occur, and if a risk factor is absent or removed, a reduction will probably ensue. This differs from markers, which generally result from a disease, vary over time and contribute to the natural history of disease progression (Salvi et al. 1997b)</p>
<p>1.1.1 Diabetes</p>
<p>Diabetes entails a risk of periodontitis, with an odds ratio of 2 to 3 for diabetics, as compared to non–diabetics (Salvi et al. 1997b). The increase in susceptibility seems to be associated more with an aberrant host–response (Salvi et al. 1997a;c) than with differences in the microbiota (Mandell et al. 1992). Diabetics may increase susceptibilityto periodontitis by impairing neutrophil chemotaxis and phagocytosis (McMullen et al. 1981). Moreover, monocytes from patients with diabetes secrete more prostaglandin E, TNF– and interleukin–1 after stimutalion with lipopolysaccharide (Salvi et al. 1997a; Salvi et al. 1998).</p>
<p>1.1.2– Smoking</p>
<p>Smoking is a well–accepted risk factor in periodontitis. In a meta–analysis, Papapanou (1996) confirmed that smoking is a risk in periodontitis, with an odds ratio of 2.8. The pathogenic mechanisms underlying this are not clear. regarding subjects with gingivitis, no differences were found between smokers and non–smokers in the composition of microbiota or the plaque accumulation rates (Bergström &amp; Preber 1994). Preber et al. (1992) reported that patients with periodontitid who smoke do not differ from those who do not, with respect to possible periopathogens. However, Zambon et al. (1996) reported that smokers had ssignificantly higher levels of B. forsythus and were at significantly greater risk of infection with this periodontal pathogen than non–smokers. Smoking causes several changes in the response to inflammation – e.g., it can impair the chemotaxis and phagocytosis of normal peripheral neutrophils (Kraal &amp; Kenney 1979) and alter their oxidative bursst (Ryder et al.1998). Locally, Numabe et al. (1998) showed that salivary neutrophilis intensify their phagocytic activity after smoking.</p>
<p>1.1.3– Genetic</p>
<p>the clearest evidence of genetic factors in adult periodontitis ccomes from periodontal findings in adult twins. More than 50% of the variance in several clinical and radiographic measures appears to be explained by genetic factors (Michaliwicz et al. 1991a; Michaliwicz et al. 1991b; Corey et al. 1993).</p>
<p>Kornman et al. (1997) showed that a composite genotype including 2 polymorphisms in the cluster of IL–1 genes (allele 2 of IL–1B +3953 plus allele 2 of IL–1A –889) was significantly overrepresented in the severe periodontitis group. Gore et al. (1998) found that the frequency of IL–1 genotypes, including the IL–1 + 3953 allele 2 (IL– 1 + 3953 1/2 and IL–1 + 3953 2/2), previously correlated with increased IL–1 production, was significantly higher in patients with advanced than in those with early–to–moderate adult periodontitis.</p>
<p>2. Neutrophils</p>
<p>Neutrophils are produced in the same bone mmarrow, where the myeloid precursor cells mature to segmented neutrophils in about 9 days, and are then released into the circulation. The cells remain in the bloodstream for a relatively short time (half–life = 6–7h) and in the tissue for 1–4 days . They can be rapidly mobilized within 30 mim to the site of an bacteria. In man, neutrophils are the predoominant leukocyte in blood, comprising between 50% and 70% of the circulation pool of leukocytes.</p>
<p>Neutrophils exist in three states: quiescent, primed and actiivated. Neutrophil activation seems to be mediated by a rise in cytosolic free Ca 2+, which correlates with activation of the oxidase system. &#8220;Primed&#8221; means that the cells are &#8220;ready to go&#8221;, but await a further stimulus before the oxidase response is elicited . A resting cell can receive a priming or an activation stimulus. Only the activated cells show oxidase activity but, if the primed cell also receives an activating stimulus, the ensuing oxidase activity will be higher than that in unprimed, activated cells (Hallet &amp; Lloyds 1995). Greater chemotaxis and degranulation have also been found when neutrophils are primed with cytokines, such as TNF– (bajaj et al. 1992) and interleukin–1 (Brandolini et al. 1997).</p>
<p>Cytokines are ssolube protein mediators of immunity. They produce their effects on target cells via specific membrane receptors. Cytokines are generally rather small polypeptides (17 – 20 kDa), which are divided into four major groups: interferons, TNF, interleukins (IL) and growth factors. Most of them are not stored in secretory granules, but are synthesized when needed (Leffell 1997). Although T–cells, natural killer cells and monocytes/macrophages produce large amounts of cytokines, nearly all cells infiltrating an inflamed tissue are neutrophils, which may therefore be a large source of cytokines. At least two interleukins, IL–1 and IL–8, have a strong association with neutrophils and periodontal diseases.</p>
<p>A relation between interleukin–1 (IL–1) and perioddontal disease has been reported in many studies. IL–1 is a potent proinflammatory cytokine that can influence the host–response in the periodontal lession. It is produced in and forms, wich are different gene productos, but utilize the same cellular receptor. Both are produced mainly by macrophages, but alsso partly by other cells, including neutrophils (Tokoro et al. 1996; Galbraith et al. 1997). IL–1 is the major inflammatory cytokine in gingival tissue associated with periodontitis (Tokoro et al. 1996). It is formed and released in response to several immunostimlatory agents – e.g., lipopolysaccharide (LPS) and tissue degradation products (Hanazawa et al. 1985) – and can activate endothelial cells to upregulate ICAM–1 and E–selectin expression (Bevilacqua et al. 1985; Carlos &amp; Harlan 1994), wich may increase the diapedesis of leukocytes. IL–1 has also been found to activate osteoclasts (Dewhirst et al. 1985). All these IL–1effects increase the inflammatory response and can subsequently cause degradation of the periodontal ligament and alveolar bone.</p>
<p>Interleukin–8 (IL–8) is a small cytokine that exhibits chemotactic activy against neutrophils, but not against nmonocytes 8Harada et al. 1996). It can be produced in vitro by a wide variety of cell types, including monocytes, lymphocytes, neutrophils and keratinocytes (mukaida et al. 1995). Il–8 is not constitutively produced, but occurs in response to an inflammatory stimulus and has a strong effect on the migration and activation of neutrophils – e.g., it can induce the degranulation of neutrophils (Brandolini et al. 1997).</p>
<p>2.1 Antimicrobial functions</p>
<p>The neutrophil recognizes and combats foreing substances by their receptors for several surface structures – for instance, the fc–portion of attached antibodies, complement factors, capsule reactive proteins and the LPS–complex. Antibodies(especially IgG) and complement proteins like C3b can opsonize and are therefore referred to as &#8220;opsonins&#8221;. Opsonization is the process whereby particles such as micro–organisms become coated with molecules, which allow them to bind to receptors on phagocytes.IgG antibodies bind to the antigens in the Fab region,leaving the Fc region sticking out. phagocytes have Fc gamma receptors(FcR) and they can therefore bind to the coated molecules and internalize them.</p>
<p>Three classes of FcR are currently distinguished: (1) FcRI (CD64) – a 72 kDa high–affinity receptor for IgG, constitutively expressed on monocytes, macrophages,myeloid progrenitor cells and dendritic cells; (2) FcRII (CD 32) –a broadly distributed 40 kDa molecule, found in most types of blood leukocytes, &#8220;Langerhans&#8221; cells, various populations of endothelial cells, dendritic cells, macrophages and platelets; and (3) FcRIII (CD16) – a glycoprotein having a molecular weight ranging from 50 – 80 kDa with two gene expressions. The FcRIIIA gene product is a transmembrane receptor named FcRIIIa, found on natural killer cells, macrophages, subpopulations of T–cells and fresh isolated blood monocytes, immature thymocytes and placental trophoblasts. The FcRIIIB gene product is FcRIIIb, which is celectively expressed on neutrophils (for a review, see Rascu et al. 1997).</p>
<p>Activated neutrophils csn destroy foreign substances by at least three mechanisms: 1) respiratory burst, 2) cytolysis and 3) phagocytosis and degranulation.</p>
<p>2.1.1 Respiratory burst</p>
<p>The respiratory burst realeases highly reactive oxygen metabolites extracellularly. Oxidative metabolism mainly generates hypochlorous acid (HOCI), because of the relatively high concentration of CL in plasma (Weiss 1989), which has both tissue–destructive and antimicrobial effects.</p>
<p>2.1.2 Cytolysis</p>
<p>This is a mechanism by which antibacterial substances reach the bacteria. Considering the high concentration of neutrophils in inflamed tissue, the release of antibacterial agents from dying cells may be an important host–defense mechanism(McNamara et al. 1988).</p>
<p>2.1.3 Phagosytosis and degranulation</p>
<p>Phagocytosis is a process in which the neutrophil isolates the organism intracellulary by creating a phagosome . Fusion between the phagosome and cytoplasmic granules deliveres high concentrations of antibacterial substances into the vacuole.</p>
<p>Degranulation leads to the release of anti–bacterial substances extracellularly(Wright 1988) from the primary (azurophil) granule(defensins, lysozyme, myeloperoxidase, cathepsin G and elastase) and the secondary 8specific) granule 8lactoferrin, collagenase and lysozyme). A tertiary granule containing gelatinase has also been described (Dewald et al. 1982). The degranulation of the primary and secondary granules is of special interest in this study. Bentwood &amp; Henson(1980) reported that human neutrophils respondednto soluble stimuli withh sequential release of, first, the secondary(specific) granule constituent, followed by the constituents of the primary granule.</p>
<p>2.2 Neutrophils and tissue destruction</p>
<p>Neutrophils are associated with tissue destruction in chronic inflammation – e.g., adult respiratory ditress syndrome (Lee et al. 1981) and emphysema(Janoff 1985). During periodontal inflammation, increased numbers of neutrophils have been found in sevarel morphologic studies of the inflamed gingiva. Attström &amp; Egelberg (1970) examined leukocytes in clinically healthy and chronically inflamed sites in humans and dogs. The leukocytes were present in both healthy and inflamed sites. Differential counts showed 95–97% neutrophils, 1.2% lymphocytes and 1–3% monocytes.The proportions remained the same, although the number of leukocytes increased with inflammation. In another study by the same author (Attström 1971), leukopenia was induced with nitrogen mustard and with heterologous anti–neutrophil serum in dogs having chronically inflamed gingiva. The leukopeina rediuced the number of crevicular leukocytes, the enzymatic activity and the volume of gengival crevicular fluid. Kowashi et al.(1979), who counted neutrophils in gingival washings during experimental gingivitis in man, found a doubling of the number of cells from day 0 to day 20. Although the local number of neutrophils are associated with the degree of inflammation, it is not conclusively shown that a marginal chronic gingivitis evolves into a perodontitis lesion. Gustafsson et al. (1994) showed that, in chronic gingivitis and in periodontitis sites, the numbers of neutrophils seem to be very similar, supporting the concept that hyperactivity per cell, rather tham differences in the local cell numbers, is important for initiation of tissue destruction.</p>
<p>The term &#8220;hyperactive&#8221; was chosen to describe higher activity of neutrophils in an inflamed site, while &#8220;hyperreactive&#8221; was chosen to describe higher reactivity of peripheral after in vitro activation. Studies of peripheral neutrophils from patients with juvenile periodontitis, uisng the production of oxygen radicals as a marker for neutrophil activity, have shown hyperreactivity after Fc–receptor stimulation (Asman 1988; whyte et al.1989; Shapiran et al.1991). The same phenomenon has recently een seen in adults with periodontitis(Gustafsson &amp; Asman 1996; Fredriksson et al. 1998). Chollet–Martin et al.(1992) called &#8220;hyperresponsive&#8221; a subpopulation of neuttrophils, isolated from patients withacute respiratory distress syndrome(ARDS), which showed an increased capacity to generate hydrogen peroxide (H2O2). Although the hyperreactivity of neutrophils from periodontitis patients might be related to the generation of oxygen species other than HO (Fredriksson et al.1998), the accumulating neutrophils may produce extensive tissue damage by generating reactive oxygen species in both diseases.</p>
<p>Besides reactive oxugen species, there are strong indications that neutrophil proteases can injure the lung and periodontal tissues. Neutrophil proteases can degrade lung and arterial–wall elastin(Janoff &amp; Zeligs 1968), cause emphysema in animal(Weinbaum et al. 1974) and collagen degradation(Janoff 1983). Increased amounts of neutrophil–derived substances, such as (beta)–glucuronidase(Lamster et al. 19949, neutrophil collagenase(Overall et al. 1987) and elastase(Gustaffsson et al. 1992), have been found in GCF in deen pockets in periodontitis patients.</p>
<p>The release of elastase from in vitro–activated peripheral neutrophil has been shown to differ significantly in patients with juvenile periodomtitis, as compared to healthy controls(Asman 1988), but it has not been shown in patients with adult periodontitis.</p>
<p>2.2.1 Neutrophil elastase</p>
<p>One of major end–products of neutrophil activity is the extracellular release of active and inactive proteases. Elastase is a neutral serine protease(33kDa), synthesized primarily in promylocytes and stored in the cytoplasmatic azurophil granules of maturing neutrophils in amounts ranging up to 3 picogramas per cell(Janoff 1985). Although neutrophils contain large amounts of elastase, they have no elastase mRNA transcripts, indicating that matureneutrophils cannot produce this enzyme. The expression of the elastase gene is limited to a very short period in leukocytes differentiation(Fouret et al. 1989).</p>
<p>Elastase can degrade many important proteins the extracellular matrix, such as elastin (Janoff &amp; Zeligs 1968), laminim (Heck et al. 1990), fibronectin and collagen (Janoff 1985, Owen &amp; Campbell 1995). The destructive capacity of released elastase is usually offset by the protease inhibitors –1–antitrypsin(A1AT) and –2–macroglobulin (A2NG). A1AT (52 kDa) seems to be the main regulator of elastase. This is a glycoprotein synthesized in the liver, and it can also be produced locally by macrophages and neutrophils(Bois et al. 1991; Pääkkö et al.1996). Normally, A1AT is present in such abundance that all active proteases are inhibited within milliseconds. However, elastase can avoid inhibition by three mechanisms: 1) when the enzyme is released in closed compartments in concentrations sufficient to overwhelm the available inhibitor; 2) release of enzyme in close proximity to its substrates, which then successffully compete with A1AT ti bind elastase; 3) enzyme released in sites where local A1AT molecules have been inactivated by oxidation.</p>
<p>The respiratory burts generates reactive oxygen radicals that are released extracellularly. Oxigen radicals are tissue–destructive per se (Weiss 1989), but they can also act in concert with simultaneously released proteases. Extracellularly–released oxigen radicals can oxidatively inhibit A1AT and thus allow the proteases to degrade matrix proteins close to the neutrophils (Weiss 1989). The facilitation of neutrophil elastase activity by oxidative inactivation of an inflammatory reaction. It can degrade tissue inhibitors of metalloproteinases (Weiss 1989) and, at the same time, may be involved in the extracellular activation of latent metalloproteinase (Ferry et al. 1997). Elastase is able to activate pro–geletinase B, which is one of the majo factors in neutrophil migration across the basement membrane (Delclaux et al. 1996) while causing extensive damage to the basement membrane by degrading laminin (Heck et al. 1990).</p>
<p>Several studies have shown increased elastase activity against specific low molecular weight substrates in periodontitis (e.g., Gustafsson et al. 1994; Ingman et al.1994) and increased levels of elastase activity have also been suggested as a perdictor of periodontal disease progression8Palcnis et al. 1992; Armitage et al. 1994). Such substrates are hydrolyzed by free elastase and bound to A2NG (Travis &amp; Salvesen 1983). This means that measurements of elastase activity with these substrates cannot distinguish between free elastase and the elastase–A2MG complex. Moreover, to our knowledge, the presence of free elastase activity in GCF from patients with adult periodontitis has not been convincingly shown.</p>
<p>In summary, elastase is very important for normal tissue turnover and for combating infection, but an excessive release in the active form together with a higher production of oxigen radicals, might cause partial inactivatiion of the major inhibitor, A1AT, and thus lead to extensive tissue destruction.</p>
<p>III – AIMS</p>
<p>The main goals in the thesis were: (1) to detect protease activity that might explain differences in site–specific tissue destruction; (2) to find in vitro evidence of peripheral neutrophil hyperreactivity related to the release of elastase; (3) to determine whether increased levels of interleukin–1(beta) could explain the local neutrophil hyperreactivity; (4) to show that inflamed sites from periodontits patients have more activated neutrophils tham inflamed sites from healthy controls, by measuring basement membrane degradation; (5) and to determine whether there is a relation between levels of IL–8 and site–specific tissue destruction.</p>
<p>1. Specific aims</p>
<p>Paper I – To determine whether free protease activity is present in GCF.</p>
<p>Paper II – To determine whether free elastase is present in GCF.</p>
<p>Paper III – To determine whether there free differences in the release of first and secundary granule between peripheral neutrophils from periodontitis patients and healthy controls.</p>
<p>Paper IV – To test the hyputhesis high levels of IL–1(beta) in GCF are characteristicof patients with periodontitis.</p>
<p>Paper V – To test the hypothesis that the presence of hyperactive neutrophils generates more basement membrane degradation in the inflamed sites of periodontitis patients.</p>
<p>IV MATERIAL AND METHODS</p>
<p>1– Clinical parameters</p>
<p>The presence of supraginginval plaque (PI) and gingival inflammation(GI) were recorded using the criteria of Silness &amp; Löe (1964) (Papers I, II, IV and V). Only sites with a GI value of 1 or 2 were included. In sites without inflammation (value 0), the volume of gingival crevicular fluid (GCF) was insufficient to permit measurement. It was usually impossible to examine very infalmed sites (GI=3), because of difficulty in avoiding contamination with bllod. Pocket depht was measured with calibrated periodontal probe.</p>
<p>2– Gingival crevicular fluid samples</p>
<p>In Papers I and II, GCF samples ewrw collected with repeated intracrevicular washings, as described by Salonen &amp; Paunio (1991), to avoid retention of free elastase in the more commonly used paper strips (Gustafsson 1996). Each pocket was washed five times with 5l of PBS during continuous aspiration . All samples from sites in the same category in each person were pooled and diluted with PBS up to 1 ml. Since one can not measure the volume of GCF with the intracrevicular washing method, we related protease activity to the concentration of transferrin in the wash–fluid, to obtain a semiquantitative estimate (Asma et al.1981). The amount of transferrin in GCF increases with fluid volume, probably because of leakage from plasma(Adonogianaki et al. 1994) and can therefore, be viewed as a marker of GCF volume.</p>
<p>In Papers IV and V, the sites were sampled with paper strips. The strip was inserted into the pocket until mild resistance was felt and kept there for 30sec. The volume of GCF was measured with a Periotron 8000 ®GCF meter: Before each study, the unstrument was calibrated, using saline delivered with a Hamilton syringe.</p>
<p>3– Protease activity</p>
<p>Free preotease activity was measured with FITC–conjugated casein. The mixture of casein and sample and incubated for 20h at +37°C, during agitation. After incubation, trichloroacetic acid 0.6M/l was added to stop the reaction and percipitate the intact casein molecules. After 30 minutes, the samples were centrifuged at 3000g for 10 minutes. The amountesof FITC–conjugated cassein fragments in the aupernant corresponds to the amount of protease activity in the samples. Fluorescence was analysed in a fluorescence spectrophotometer, at an excitation wavelength of 488 nm and an emission wavelength of 520 nm.</p>
<p>4– Elastase activity</p>
<p>The levels of elastase activity were measured with the low molecular weight substrate(445.5 Da) L–pyroglutamy–L–propyl–L–valine–p–nitroanilide. The substrate is highly specific for granulocytes elastase(Tanaka et al. 1990) but it is also hydrolyzed by the elastase––2–macroglobulin complex (Wewers 1988). To distinguish between activity derived from free elastase and elastase bound to A2NG, an excess amount of A1At was added to the samples. A1AT is a very effective inhibitor of free elastase activity, but it can innhibit activity from the elastase bound to A2MG (Travis &amp; Salvesen 1983). The activity inhibited by A1AT could thus be seen as derived from free elastase and the remaining activity from the elastase–A2MG complex.</p>
<p>5– ELISA assays</p>
<p>5.1 –Elastase – A1AT complex</p>
<p>A polyclonal antibody against A1AT was coated on a 96–well microtitre plate overnight at + 40°C. The wells were washed five times with PBS + 0.05% Tween ®20. Samples or standards were added to each well and incubated for one hour at +37°C. The wells were washed again, as above. and an alkanline phosphate–conjugated polyclonal sheep antibody aginst elastase was added and incubated for one hour at + 37°C. After a final washing, the substrate p–nitrophenol–phosphate was added to each well and the absorbance was read after 10 min at 405 nm in a spectrophotometer.</p>
<p>5.2– Antigenic elastase</p>
<p>A monoclonal antibody against elastase was coated on a 96–well microtitre plate overnightnat +4¼C. The wells were washed four times with PBS + 0.05% Tween®. Diluted samples or standards were added to each well and incubated for 1h at +37¼C. The wells were washed again, as above, and a polyclonal sheep antibody against elastase was added to them and incubated for one hour at + 37¼C. After another wash, the third antibody, an alkaline phosphatase–conjugated rabbit ant–goat IgG, was added and incubated, as above. After a final washing, the substrate p–nitrophenol–phosphate was added to each well. The absordance at 405nm was read in a spectrophotometer after 10 min. The antigenic elastase assay does not detect elastase bound to A2MG.</p>
<p>5.3– Lactoferrin</p>
<p>A microtitre plate was coated with a monoclonal mouse antibody against lactoferrin and incubated overnight at + 4¼C. The wells were washed five times with PBS + 0.05% Tween¨. Samples and standards were added to the wells and incubated for one hour, washed once again and the second antibody, a polyclonal rabbit anti–lactoferrin, was added. The plates were incubated for one hour at +37¼C and washed five times before adding of the third antibody, an alkaline phosphatase–cconjugated polyclonal goat antibody against rabbit IgG, and incubating for one hour. The phosphatase activity was measured after the additing of the substrate p–nitrophenol– phosphate and the absorbance at 405 nm was read in a spectrophotometer after 10 minutes.</p>
<p>5.4– –1–antitrypsin (A1AT) and –2macroglobulin (A2MG)</p>
<p>Antigenic A1AT and A2MG were measured with a one –layer ELISA. The microtitre plate was coated with samples and standard, diluted in carbonatee buffer, pH 9.6, and icubated overnight at +4¼C. After incubation, the plate was washed four times with PBS + 0.05% Tween¨. The antigen was detected with a polyclonal rabbit antibody against A1AT or A2MG during incubation at +37¼C for one hour. After another washing, as described above, the final antibody, a goat anti–rabbit IgG conjugated with alkaline phosphatase, was added. The plate once again incubated at +37¼C for one hour and washed, as above. The phosphatase activity was measured after the addition of the substrate, p– spectrophotometer after 10 minutes.</p>
<p>5.5– Interleukin–1 andInterleukin–8</p>
<p>A monoclonal antibody to IL–1 or IL–8, diluted in carbonate buffer, was coated onto the microtitre plates overnight at +4¼C. After the coating, the plates were washed four times with PBS+0.05% Tween, blocked with 1% HSA, and incubated for 1h at room temperature. After washing, as above, a standard curve and samples were coated onto the plates. The plates were incubated at +37¼C and shaken for 45 min and washed as above. The detection antibody, a biotinylatedpolyclonal goat anti– IL–1 or IL–8, was incubated at +37¼C and shaken for 45min. After washing, as above, the horse radish peroxidase (HRP)–conjugated streptavidin was added to the plates and incubated in the same way as the detection antibody. The plates were washed once again, as above, before the HRP–substrate, 3,3«, 5,5«–tetramethyl–benzidine, was added. The reaction was stopped with 1M H2SO4 after approximately 10min and the absorbance at 450 nm was read in a spectrophotometer.</p>
<p>5.6– Laminin</p>
<p>the standard curve and diluted samples were added to the microtitre plates and incubated overnight at +4¼C. After washing the plates, a polyclonal rabbit antibody against laminin, diluted in PBS + 0.1%HSA, was used as a primary antibody. The plates were then incubated during shaking 45 min at 37¼C. After another washing, the second antibody, a biotinylated polyclonal goat anti–rabbit IgG diluted in PBS+0.1% HSA, was added and incubated during shaking at +37¼C fro 45 min. After a third wash, as above, HRP–conjugated streptavidin was added to the plates and incubated in the same way as the detection antibody. The plates were once again washed, as above, before the HRP–substrate, 3,3« , 5,5«–tetramethyl–benzidine, was added. The reaction was stopped with 1M H2SO4</p>
<p>5.6– Laminin</p>
<p>the standard curve and diluted samples were added to the microtitre plates and incubated overnight at +4¼C. After washing the plates, a polyclonal rabbit antibody against laminin, diluted in PBS + 0.1%HSA, was used as a primary antibody. The plates were then incubated during shaking 45 min at 37¼C. After another washing, the second antibody, a biotinylated polyclonal goat anti–rabbit IgG diluted in PBS+0.1% HSA, was added and incubated during shaking at +37¼C for 45 min. After a third wash, as above, HRP–conjugated streptavidin was added to the plates and incubated in the same way as the detection antibody. The plates were once again washed, as above, before the HRP–substrate, 3,3« , 5,5«–tetramethyl–benzidine, was added. The reaction was stopped with 1M H2SO4 after approximately 40 min, and the absorbance at 450nm was read in a spectrophotometer.</p>
<p>5.7– Transferrin</p>
<p>Samples and standards were coated on a 96 micro–well plate overnight at +4¼C. After incubation, the plate was washed four times with PBS +0.05% Tween. One hundred l of a polyclonal rabbit antibody against trasferrin was added to the plate and incubated for onw hour +37¼C. The plate was washed again and the second antibody, an alkaline phosphatase–conjugated swine anti–rabbit immunoglobbulin, was added. After one more hour if incubation and still another wash, 100 l of the substrate p–nitrophenol–phosphate was added. The absorbency at 450nm was read after 30 min in a spectrophotometer.</p>
<p>6. Flow cytometric analysis</p>
<p>To confirm the presence of intrcellular stores of A1At, 250 000 leukocytes were fixed and permeabilized. After permeabilization, 2l of a rabbit polyclonal antibody against A1AT was added to the cells and incubated for 20 min during aditation, followed by the addition of 2l of a FITC–conjugated polyclonal swine antibody against rabbit IgG. A rabbit IgG fraction was used as the negative control. Flow cytometric meassurements were mada after gating the subpopulations on a histogram with foward– and side– scatter. The mean fluorescence intensity and the staining in percentage were recorded.</p>
<p>7– Cell Preparation</p>
<p>Venous blood was collected into vacuum tubes containing EDTA and allowed to rest for 1 hour at room temperature. A leukocyte–rich preparation from 7ml of venous was made by lysing the red blood cell in whole blood at 4¼C for 10 min. with 0.83% NH4Cl solution (NH4 Cl 8.3g, KHCO3 1.0g, Na2 EDTA 2H2O 0.04 g and distilled water to 100 ml) suplemented with 0.25% HSA, ratio of blood to reagent = 1:7. After centrifugation (350 g, 5 min), the harvested leukocyte pellet was washed twice with PBS/HSA and stored at + – 0¼C in the same buffers for one hour.</p>
<p>8– Degranulation</p>
<p>The leukocytes (1.0 x 106 netrophils) stored in PBS + 0.25% HSA, were mixed with IgG–opsonized Staphylococcus aureus (75 bacteria per neutrophil) (Bergström &amp; Asman 1993). Tubes without bacterial stimulation were used as controls for each subject. The mixture was further diluted with Hankks«Balanced Salt Solution up to a final reaction volume of 1 ml, and incubated for one hour during horizontal agitation. The reaction was stopped by centrifuging at 1000 g for 5 minutes. The supernatant was removed and stored at –70¼C, pending analysis. the pellet containing the leukocytes was diluted up to 1ml with distilled watter and the cells were homogenized by repeated freezing and thawing (four times), centrifuged again (1000g for 5 min.) to remove the cell fragments and stored at –70¼C, pending analysis.</p>
<p>9– Statistical analysis</p>
<p>The significances of differences between patients and controls were calculated with the Mann–Whitney U–test and of differences between the categories of sites in periodontitis patients with the Wilcoxon signed–rank test. The correlations were calculated with the Spearman rank correlation coefficient or the Kendall rank correlation coefficient.</p>
<p>V– RESULTS</p>
<p>In Paper I, we measured non–specific protease activity in GCF from inflamed sites with or without tissue ddistruction. The clinical findings are shown in Table 11. The free protease activity was higher in samples from inflamed sites with tissue destruction in subjects having periodontitis (PP), than in samples form inflamed sites without such destruction in the same subjects (GP) and samples from subjects with gingivitis alone (GG). The difference between PP and GP was significant (p=0.0019). There was a large variation in protease activity, but the highest activities were found mostly in samples from the periodontitis patients. PP showed a mean protease activity, corresponding to 230 ng trypsin (SD± 481.6), 52 ng in GP (SD±174.7) and 25 ng in GG (SD± 33.6). Median values are presented in Table 2. The residual protease activity, i.e. the activity measured after the addition of excess A1AT, was usually low in the GP samples than in GG and PP samples. The addition of A1AT inhibited a larger proportion of the protease activity in the GP sample than in the GG and PP samples (Table 2). The transferrin concentration was significantly lower in the GP samples than in the other two categories . We found no difference between GG and PP samples. The ratio of protease activity to trasnferrin was higher in PP than in GP. A significant difference was observed between GP and PP (p=0.0001) (Table 2).</p>
<p>Table 1. Comparison of mean values of clinical findings (± standard deviation) between GG (gingivitis in gingivitis patients), GP (gingivitis in periodontitiss patients) and PP (periodontitis in periodontitis patients). GI– gingival index; PI plaque index; PPD–probing pocket depth.<br />
 GG (n12)     GP (n19)     PP (n:19)<br />
 GI     1.0 (±0.4)     1.1 (±0.3)     1.3 (±0.4)<br />
 PI     0.9 (±0.5)     1.3 (±0.6)     1.5 (±0.5)<br />
 PPD (mm)     1.7 (±0.7)     2.4 (±0.6)     6.3 (±0.9)</p>
<p>Table 2. Median of protease activity (after inhibition with A1AT) expressed in ng, median of the amounts of transferrin expressed in ng, the ratio between protease activity and transferrin and mean of protease inhibition expressed as a %.<br />
 Test / Site     GG     P1     GP     P2     PP     P3<br />
 Protease activity     15.7     NS     5.0     p&lt;0.002     56.9     NS<br />
 Residual activity     2.1     NS     0.3     p=0.02</p>
<p>2.2     NS<br />
 Transferrin     355.1     p&lt;0.04     194.6     p=0.003     345     NS<br />
 protease/transf     0.038     NS     0.023     p&lt;0.001     0.140     NS<br />
 Mean inhibition     86     NS     94     p=0.041     88     NS</p>
<p>P1: Differences between GG and GP, calculated with Mann – Whitney U–Test. P2: Differences between GP and PP, calculated with Wilcoxon signed–rank test. P3:Differences between GG and PP, calculated with Mann–Whitney U–teste.</p>
<p>In paper II, elastase activity was measured with a low molecular weight substrate and elastase bound to A1AT was measured with with an ELISA. To distinguish between free elastase and elastase bound to A2MG, we added an excess of A1AT to the samples. The activity inhibited by A1AT was considered as free elastase and the uninhibited activity as derived from the elastase–A2MG complex (c.f. materials and methods, page 19). The amounts of free elastase, total elastase and elastase bound to A2MG, were significantly higher in PP than in GP and GG (Table 3; Fig. 1). There were no significant differences in the amounts of ealstase bound to A1AT betwenn the groups. Mean values are shown in Table 3.</p>
<p>The amounts of transferrin in the wash fluid were similar in the PP and GG sites while they low in the GP sites. Since the distribution was skewed, the median concentration of transferrin is shown in Table 3 .</p>
<p>The ratio of total elastase to tranferrin was significantly higher in PP samples than in GP and GG samples. The ratio between free elastase and transferrin was also significantly higher in PP sites than in Gp and GG sites. It was almost twice as high in GP sites as in clinically similar GG sites(table 3). The was a strong negative correlation between the percentage of free elastase and the percentage of A1AT complex (R= – 0.93) calculated in all samples, n= 50 (Fig.2). We found a positive correlation between free elastase and the non–specific protease activity analyzed previously(Paper I), R= 0.41 in GG and 0.71 in PP (date not shown).</p>
<p>Table 3. Mean values of total elastase, free elastase, elastase inhibited by –1–antitrypsin (A1AT) and by –2–macroglobulin (A2MG), exprressed as cell equivalents x 10(3). The ratios of total elastase to tranferrin and of free elastase to transferrin are expressed as mean the amounts of transferrin are expressed as median.<br />
 Test / Site     GG (n12)     P1     GP (n 19)     P2     PP (n19)     P3<br />
 Total elastase     67.5     NS     64.3     &lt;0.001     162.9     0.005<br />
 Free elastase     17.7     NS     28.8     &lt;0.001     79.9</p>
<p>0.007<br />
 Elastase – A1AT     42.8     NS     27.6     NS     61.8     NS<br />
 Elastase A2MG     8.4     NS     9.6</p>
<p>0.001     21.1</p>
<p>0.014<br />
 Free elastase/transf     59.7     NS     104.5     0.025     339.0     0.012<br />
 Total elastase/transf     148.6     NS     263.4     0.05     572.5</p>
<p>&lt;0.001<br />
 Transferrin – ng     355     0.036     195     0.003     345     NS</p>
<p>p1: Differences between GG and GP, calculated with the mann–Whitney u ––test. p2: Differences between GP and PP, calculated with the Wilcoxon signend–rank test. p3: Significance of differences between GG and PP, calculated with the Mann–whitney u –test. NS: not significant.</p>
<p>Fig.1. Mean values of total elastase, free elastase, and of elastase bound to A2MG and to A1AT, expressed in cell equivalents x 10(3).</p>
<p>Fig.2. Correlation between the percentage of a free elastase and the percentage of elastase –– 1–atitrypsin complex (A1AT) in all samples (n = 50).</p>
<p>In Paper III, we found that the release of elastase from peripheral neutrophils after stimulation with opsonized bacteria was significantly higher in patients with periodontitis than in healthy controls (p= 0.01) (Table 4, Fig.3). There was also a significant difference between the groups in the unstimulated sample s(p= 0.024)(Table 4). The total amount of elastase, i.e. the sum of the elastase activity released and the remaining activity in the cells, were similar in the unstimulated samples from the two groups. During bacterial stimulation, however, the total amount of elastase increased in samples from patients (p= 0.013). In contrast, no corresponding increase could be seen in the control group(Fig. 4). The total amount of A1AT and the amount of elastase –A1AT complex in the supernatant from the stimulated cells were higher than from the unstimulated cells in both patients and controls, but the differences between the groups were not significant (Table 4). The flow cytometric analysis showed that the granulocytes contained intracellular stores of A1AT and that only negligible amounts of the inhibitor were present in monocytes and lymphocytes. The release of lactoferrin, used as a marker of the release of secondary granula, was the same in both groups.</p>
<p>Table 4. Significances of differences in elastase released, total elastase–A1AT complex (E–A1AT), total A1AT and lactoferrin. The degranulation was analysed in four groups: CO – Control subjects without bacterial stimulation; CB – Control subjects after bacterial stimulation; PO – Patients without bacterial stimulation and PB – Patients after bacterial stimulation.<br />
 CO – CB*     PO – PB*     CO – PO**     CB – PB**     pairs<br />
 Elastase released     0.002     0.001     0.024     0.010     15<br />
 Total elastase     NS     0.013     NS     0.044     15<br />
 Total A1AT     0.041     0.002     NS     NS     13<br />
 E–A1AT complex     0.007     0.002     NS     NS     13<br />
 Lactoferrin     0.012     0.008     NS     NS     10</p>
<p>* Significance of difference calculated with the Wilcoxon signed–rank test. ** Significance of difference calculated with the Mann–Whitney U – test. NS not significant.</p>
<p>Fig.3. Elastase activity, expressed as cell equivalent x 10(3), released from peripheral neutrophyls during Fc R–mediated simulation for 60 min in 15 healhy controls and 15 patients with adult periodontitis. Horizontal bars indicate mean.</p>
<p>Fig.4. Mean values of elastase activity released extracellularly and elastase extracted from the pellet (expressed as cell equivalents x 10(3). Samples from 15 control subjects incubated in Hank&#8217;s buffer with opsonized bacteria (CB) or in Hank&#8217;s buffer alone (C0) and from 15 patients with (PB) or without simulation by bacteria (P0).</p>
<p>In Paper IV, we measured the concentration of IL–1 and the elastase activity in GCF samples from untreated subjects with periodontitis and gingivitis. The plaque index (PI), gingival index (GI) and the volume of GCF collectec were similar in the periodontitis sites from patients and in the gingivitis sites fromhealthy controls, but the values were lower in inflamed shallow pockets from periodontitis patients (Table 5). No significant correlations, were found between the clinical data at various sites and the IL–1 concentrations, with the exception of GCF volume, were a significant positive correlation was found (p&lt;0.001) (data not shown).</p>
<p>Both the concentration and the total amount of IL–1 were significantly higher in shallow (GP) and deep pockets (PP) in patients with periodontitis than in gingivitis sites(GG) in healthy sobjects. No signgficant difference was noted between GP and PP. PP also showed higher elastase activity, althogh the difference was not signgficant (Tables 6a and b). A weak positive correlation was present between elastase activity and IL–1 (p= 0.06). This correlation was most pronounced in the GG samples (p= 0.03).</p>
<p>The amount of elastase–A1AT complex was significantly higher in PP tahn in GG and GP(Table 6b). The concentrations of E–A1AT, A1AT and A2MG were similar in the three types of sites (Table 6a).</p>
<p>Table 5. Comparison of mean values at various sites in 13 subjects with gingivitis and 18 patients with periodontitis. GG– gingivitis sites in gingivitis in patients.GP– gingivitis sites in periodontitis patients,PP– periodontitis sites in periodontitis patients. PI– plaque index; GI– gingival index; PPD– probing pocket depth expressed in mm and GCF– gingival crevicular fluid expressed in l.<br />
 Site     GG     p1     GP     p2     PP     p3<br />
 PI     1.7     NS     1.2     0.001     1.7     NS<br />
 GI     1.7     0.05     1.4     0.003     1.9     0.021<br />
 PPD     1.9     NS     2.1     0.001     6.1     0.001<br />
 GCF     1.8     0.013     1.3     0.006     1.9     NS</p>
<p>p 1 : Differences between GG and GP, calculated with the Mann–Whitney U –test. p 2: Differences betwenn GP and PP, calculated with the Wilcoxon signed–rank test. p3: Significance of differnces between GG and PP, calculated with the Mann–Whitney U–test. NS: nit significant.</p>
<p>Tables 6a and b. Mean concentrations (6a) and total amounts (6b) of elastase activity (E activity), elastase––1–antitrypsin complex(EA1AT), –1–antitrypsin(A1AT), –2–macroglobulin (A2MG) and interleukin–1 (IL–1) in GG (gingivitis sites in gingivitis patients), GP (gingivitis sites in periodontitis patients) and PP(periodontitis sites in periodontitis patients), n= 13 control subjects with gingivitis and 18 periodontitis patients.</p>
<p>Table 6a<br />
 Site     GG     p1     GP     p2     PP     p3<br />
 E activity ( cell equiv/l )     26600     NS     22400     NS     30000     NS<br />
 EA1AT (nmol/l)     0.26     NS     0.23     NS     0.44     NS<br />
 A1AT (nmol/l)     0.24     NS     0.17     NS     0.24     NS<br />
 A2MG (ng/l)     458     NS     738     NS     621     NS<br />
 IL–1 (pg/l)     2.0     0.009     5.0     NS     5.4     0.0036</p>
<p>Table 6b<br />
 Site     GG     p1     GP     p2     PP     p3<br />
 E activity ( cell equiv)     46500     0.04     27700     0.03     68500     NS<br />
 EA1AT (nmol)     0.42     NS     0.29     0.001     0.75     0.04<br />
 A1AT (nmol)     0.38     0.04     0.20     NS     0.40     NS<br />
 A2MG (ng)     656     NS     823     0.002     1164     NS<br />
 IL–1 (pg)     2.9     0.02     5.5     0.002     9.0     0.001</p>
<p>p1: Differences between GG and GP, calculated with the Mann–Whitney U –test. p2: Differences between Gp and PP, calculated with the Wilcoxon signied–rank test. p3: Significance of differences between GG and PP, calculated with the Mann–Whitney U –test. NS: not significant.</p>
<p>In paper V, we studied laminin and IL–8 in GCF samples from untreated subjects with periodontitis and gingivitis. The clinical findings are shown in table 7. The amounts of laminin were significantly higher in PP, as compared to GG, but no significant differences was noted between shallow and deep pockets in the patients group (table 8). The distribution of the amounts of laminin in the samples is shown in Figure 5. The concentrations of laminin tended to be higher in the GP samples (table 8). The amounts of IL–8 and lactoferrin were very similar in the three groups (table 8). Strong negative correlations were found when the GCF volume was correlated with the concentrations of laminin (Fig. 6) lactoferrin (Fig. 7), while no correlation with the IL–8 concentration was observed.</p>
<p>A strong positive correlation was observed between the concentrations of laminin and lactoferrin (R= 0.72,p= 0.001). This correlation was more pronouced in patients with preiodontitis (R= 0.81, p=0.003) than in control subjects (R= 0.69, p= 0.02).</p>
<p>Table 7. Mean values for PI– plaque indexm GI–gingival index, PPD– probing pocket depth expressed in mm and GCF– gingival crevicular fluid expressed in ml, in 12 subjects with gingivitis and 13 with periodontitis. GG– gingivitis sites in subjecs; GO– gingivitis sites in periodontitis patients; PP– periodontitis sites in periodontitis patients.<br />
 Site     GG     p1     GP     p2     PP     p3<br />
 PI     1.4     NS     1.6     NS     1.6     NS<br />
 GI     1.3     NS     1.7     NS     1.9     0.01<br />
 PPD     2.4     NS     2.6     0.0001     5.5     0.0001<br />
 GCF     1.8     NS     1.6     0.02     2.4     0.03</p>
<p>p1: Differences between GG and Gp, calculated with the Mann–Whitney U–test. p2: Differences between GP and PP, calculated with the Wilcoxon signed–rank test. p3: Significance of differences between GG and OO, calculated with the Mann–Whitney U –test. NS: not significant.</p>
<p>Table 8. Mean values of the total amounts and concentrations of laminin, interleukin–8(IL–8), expressed in picogramas(pg) and picogramas per microlitre(pg/ml), and lactoferrin expressed in arbritary units(a.u) and a.u/ml, in GG(gingivitis sites in gingivitis subjects) GP(gingivitis sites in periodontitid patients) and PP(periodontitis sites in periodontitis patients). N= 12 gingivitis and 13 periodontitis patients.<br />
 Site     GG     GP     PP<br />
 Laminin (pg)     287     397     385*<br />
 IL–8 (pg)     7.4     7.1     9.2<br />
 Lactoferrin (a.u.)     526.6     423.6     546.8<br />
 Laminin concentration (pg/l)     182     397     179<br />
 IL–8 concentration (pg/l)     4.4     8.9     3.8<br />
 Lactoferrin concentration (a.u./l)     352.8     378     237.1</p>
<p>* Difference between GG and PP, calculated with the Mann–Whitney U –test.</p>
<p>Fig 5. Boxplot showing the total amounts of laminin in 12 GG (gingivitis sites in control subjects), 13 GP (gingivitis sites in patients with periodontitis) and 13 PP (periodontitis sites in patients with periodontitis). Median, 10th , 25th , 75th and 90th percentiles in boxplot.</p>
<p>Fig 6. Correlation between laminin concentration and GCF volume in all samples (n= 38).</p>
<p>Fig 7. Correlation between lactoferrin and GCF volume in all samples (n= 38)</p>
<p>VI – DISCUSSION</p>
<p>The studies in this thesis show that neutrophil hyperreactivity is probaby one of the mechanisms causing tissue destruction in patients with adult periodontitis. This view is supported by the following findings: 1) sites with tissue destruction showed a higher free elastase activity than sites without; 2) neutrophils from periodontitis patients reacted more strongly against Fcy–receptor–mediated stimulation in vitro; and 3) basement membrane degradation tenteded to be greater in these patients. Moreover, such patients also have increased concentrations of interleukin–1b in gingival crevicular fluid(GCF), regardless of the degree of tissue destruction.</p>
<p>For he past few years, several authors have studied protease activity in GCF from patients with periodontitis(Ohlsson et al. 1973; Kowashi et al. 1979). Here we assessed protease activity by evaluating as the degradation of FITC–conjugated casein. Casein is degraded by most protease but, in contrast to low molecular weight substrates, not by protease complexed to A2MG. We showed that free protease activity can be detected in GCF in inflamed sites with or without tissue destruction, and that it is higher in sites with tissue destruction. The addition of A1AT to the GCF samples inhibited almost all activity(approx. 90%), suggesting that the protease activity was due to an imbalance between protease and antiprotease rather than to activity of proteases not sensitive to inhibition by A1At.</p>
<p>Elastase activity in GCF was measured with a low molecular weight substrate, highly specific for granulocyte elastase(Kramps et al. 1983). Such a substrate is hydrolyzed by free elastase and by elastase bound to A2MG (Trevis &amp; Salvesen 1983). This means that measurements of elastase activity with this substrate cannot distinguish between free elastase and the elastase–A2MG complex. To distinguish between activity derived from free elastase and elastase bound to A2MG, an excess amount of A1AT was to the samples. A1AT is a very effective inhibitor of free elastase activity, but it cannot inhibit activity from the elastase – A2MG complex(Teavis &amp; Salvesen 1983). The activity inhibited by A1AT can thus be seen as derived from free elastase and the remaining activity from the elastase–A2MG complex.</p>
<p>The total amount of neutrophil elastase was significantly higher in sites with tissue destruction and a large proportion of this elastase was free – i.e., still active against important proteins such as collagen and elastin . The free neutrophil elastase activity was stronbly correlated with the free protase activity, and showed the highest R–value in sites with tissue destructio (R= 0.71). Incontrast to our results, Giannopoulou et al.(1992) found no free elastase in GCF in patients with periodontitis. The reason for this discrepancy is not clear, but one explanation might be the sampling technique. Giannopoulou collected samples with microcapillaries, a method that may disturb gingival vessels ans cause a leakage of plasma. A large influx of plasmacould innhibit all elastase activity in GCF.</p>
<p>Higher elastase activity in sites with tissue destruction may be due to both a higher relase of elastase per all and/or an increased number of neutrophils. Gustafsson et al.(1994) showed that a higher elastase activity in GCF from periodontitis patients was due to increased release from each cell rather than to differences in the number of local cells, which mght be due to local hyperactivity of neutrophils. We studied the association between peripheral neutrophil reactivity and destructive periodontal disease by means of Fcy–receptor–stimulated elastase release. Significantly more elastase was released by in vitro–activated peripheral neutrophils from adult patients having periodontitis than by those from healthy controls. This was also true of juvenile periodontitis, using tha same type of stimulation(Asman 1988), but it has not been shown before in adult periodontitis. On the other hand , a similar study showed no differences in the release of elastase between subjects with various degrees of periodontal disease when peripheral neutrophils were activated with formyl–methionyl–leucyl–phenylalanime(fMLP) (Giannopoulou et al.1994). However, the increased degranulation of neutrophils in such patients may depend on the kind of stimuli used. Corresponding studies of oxygen radical prodiction, using Fcy–receptor–mediated stimulation, have consistently shown a difference between periodontitis patients and healthy controls(Asman 1988; Whyte et al. 1989; Fredriksson et al.1998), while studies using other methods of activation have shown conflicting results(Henry et al. 1984; Mouynet et al. 1994).</p>
<p>The higher release of elastase by peripheral neutrophils from patients with adult periodontitis might be due to a priming/activation of neutrophils already in the circulation, which could influence the intracellular activity of elastase. Elastase is present in both an active(Gardim et al. 1991) and a proenzyme form inside the azurophilic granules(Cavarra et al. 1997), but the mechanism controlling the transition from one to another is not well understood. According to Tamura et al. (1998), primed neutrophils activated with fMLP release almost twice as much elastase as fMLP activation does alone. Priming is a process that enhances the cellÕs ability to respond to a second stimulus. An increased priming response may reflect an increased susceptibility to priminig or increased amounts substances with a priming effect. Such substances may be derived from the host, e.g., proinflammatory cytokines and degradation products(Wachtfogel et al. 1988; Steinbeck &amp; Roth 1989), or from bacteria, e.g., formyl–methionyl–leucyl–phenylalanime(Allred &amp; hill 1978) and LPS(Forehand at al. 1991) . We recently found that unstimulated neutrophils from periodontitis patients expressed higher intracellular elastase activity than in those from healthy controls. Unlike elastase activity, the total amounts of antigenic elastase were similar in patients and controls(Figueredo et al. Unpublished data). This might indicated greater intracellular activation of latent elastasein perioheral neutrophils from patients with adult periodontitis.</p>
<p>Although elastase may have a salutary effect on the normal turnover of tissues and on combating infection, excessive release, especially under conditions that compromise the function of regulatory innhibitors – for instance, a–1–antitrypsin (A1AT) and a–2–macroglobulin(A2MG) – can damage tissue(for a review, see Janoff 1985). A1AT inactivates virtually all mammalian serine proteases. However, the rate of inhibition shows that elastase activity is inactivated by A1AT at a rate tenfold higher tahn of other proteases, indicating that the primary function of A1AT is to contorl neutrophil elastase activity(Travis &amp; Savesen 1983). Most A1AT is produced in the liver, but cells like macrophages and neutrophils can contribute to local production of this inhibitor. In neutrophils, A1AT is stored in the same granula as elastase, but it does not seem to bind elastase intracellularly. Elastase tends to be present in the peripheral of the granule(Gramer et al. 1989), while A1At is usually found in the granule matrix(Mason et al. 1991). One reason why elastase activity was higher in the supernatant from the patientsÕ cells could be release of A1AT. However, we found no differences in the release of A1AT that explained the increase in elastase activity. Another possibility could be differences in inhibitory capacity of the A1AT released, but this possibility was ruled out by determining the levels of the elastase–A1AT complex in the supernatantm which were also similar in patients and controls.</p>
<p>We found a strong negative correletion between the percentage of free elastase and the percentage of elastase–A1AT complex in GCF. Since the concentrations of A1AT are high in plasma and in GCF, local inactivation rather than a shortage of A1AT probably occurred, in combination with increased release of elastase. Systemic inactivation of A1AT has also been suggested in a recentstudy by our group, in whuch plasma levels of A1AT were analysed in patients with adult periodontitis and compared to those in healthy controls. We found higherconcentrations of antigenic A1AT in patients with periodontitis, but a similar A1AT protease inhibitor capacity. Moreover, when this capacity was related to the antigenic A1AT, the levels of functional A1AT had a tendency to be lower in patients with periodontitis(Fredriksson et al. Unpublished data).</p>
<p>A1AT is sensitive to oxidative and proteolytic inactivation. Thus, an excessive realease of active protease in combination with simultaneous release of oxigen radicals might cause an inactivation of A1AT and subsequent tissue destruction(Weiss 1989). A similar process has been described in patients with lung emphysema, where high levels of oxidants, mainly hydrogen peroxide, can produce a situation in which the amounts of A1AT are normal, but the functional periodontal are near zero(Travis 1988). The situation may be even worse in periodontal disease, due to the activity of microbial protease that can degrade and inactivate A1AT(Carlsson et al.1984; Travis et al. 1994).</p>
<p>Apart from A1AT; –2–macroglobulin(A2MG) can inhibit elastase and almost all other proteases in periodontitis sites. A2MG is a rapid and efficient clearing for free proteases in the circualtion (Travis &amp; Savesen 1983). We found that a higher percentage of elastase was inhibited by A2MG in samples from sites with tissue destruction, than in those without, an observation that accords with studies of GCF samples collected with paper strips (Gustafsson et al. 1994; Meyer et al. 1997). This may because impaired inhibition by A1AT is patly compensated by increased inhibition by A2MG. However, the simultaneous realease of oxigen species and proteases can also inactivate A2MG (Abbink et al.1991), which could explain the presence of free elastase in our samples. Moreover, the large molecular weight (725 kDa) of A2MG makes it difficult to compensate an extravascular deficiency/inactivation of A1AT.</p>
<p>Having assessed local peripheral differnces in elastase activity, we also wished to find a pro–inflammatory substance that might be characteristic of a given patient. IL–1 has been reported to be much higher in periodontitis sites than in healthy ones (Stashenko et al. 1991; Tsai et al. 1995; Ishihara et al.1997). This could be the result of severer inflammation and/or constitutional differences in Il–1b production. Kornman et al. (1997) and Gore et al. (1998) showed that patients with severe periodontitis have a significantly higher frequency of an IL–1 genotype associed with increased production of IL–1 in vitro (Pociot et al. 1992). We compared the levels of interleukin–1b in GCF from inflamed shallow and deep pockets in sujects without attachment loss. We found that the concentration of IL –1b in GCF is higher in periodontitis patients, even when inflamed shallow pockets in patients are compared to those in subjects with gingivitis alone. There were no significant differences in IL–1b concentration between shallow and deep pockets in the same patient. Since the GCF volumes and concentrations of elastase–A1AT, A1AT and A2MG were similar, the local degree of inflammation could be assumed to be the same in the three categories of sites. This supports the hypothesis that IL–1 is more a characteristic of a given patients and less a result of tissue destrution in the sampled site. Wilton et al. (1992; 1993) studied IL–1 levels in GCF from patients with adult periodontitis and found no correlation with plaque index, bleeding or pocket depth. Reinhardt et al. (1993) likewise found no differnce in IL–1 levels between shallow and deep pockets in patients with periodontitis. Salvi et al. (1997c) reported significantly higher IL–1 levels in GCF from patients with moderated/severe periodontitis than in those with gingivitis/mild periodontitis. However, no comparisom was made between shallow and deep pockets within the same patient.</p>
<p>Our findings differ to some extent from those of others, who have reported increasing levels of IL–1 with increasing inflammation and pocket depht (Ishihara et al. 1997; Hou et al. 1995; Yavuzylmaz et al. 1995). This may be because our subjects had not been treated and had similar degrees of inflammation in shallow and deep pockets. It seems likely that even if the level of IL–1 is characteristic of a given patient, it is also influenced by the degrees of inflammation since IL–1 is not constitutively produced, but needs external stimuli.</p>
<p>In our last investigation (Paper V), we found higher amounts of laminin in GCF from patients with adult periodontitis , suggesting the presence of hyperactivated leukocytes during the process of transmigration through the basement membranes. This difference was clearest when comparing PP and GG sites (p=0.03), but there was also a tendency towards a difference between GP and GG. However, due to the wide range of values, it did not reach significance (p=0.16). This finding indicates that these patients have more activated leukocytes that cause greater destruction of the basal membrane during their migration through the endothelium /epithelium. The high prevalence of neutrophils in the inflammatory lesions the periodontitis (Attström &amp; Egelberg 1970). Together with previous evidence of local and peripheral neutrophil hyperreactivity (e.g., Gustafsson et al. 1994; Fredriksson et al.1998), suggest that these cells act the primary mediator of local basement membrane degradation in patients with adult periodontitis . The similar amounts of lactofferrin indicated that the differences in basal membrane degradation are not due to differences in the number of neutrophils in the lesion.</p>
<p>Activated neutrophils are said to express membrane–bound neutrophil elastase om the cell membrane (Owen et al. 1995). It is an important bioactive form of enzyme, where elastase is catalytically active against extracellular matrix macromolecules but resistant to inhibition by naturally occurring protease inhibitors (Campbell &amp; Campbell 1988). Owen et al. (1995) showed that N–formyl–methiony–leucyl–phenylalanine (fMLP), complement component 5a (C5a) and phorbol myristate acetate (PMA) stimulate a dose–dependent increase in membrane–bound elastase expression. They also showed that priming neutrophils with bacterial LPS and then incubating them with fMLP induces a threefold increase in the cell surface expression of elastase, as compared to cells incubated with fMLP alone. We speculated that membrane–bound elastase activity might be the machanism by which activated neutrophils cause basement membrane degradation.</p>
<p>Even if neutrophil hyperreactivy occurs in periodontitis patients, sites–specific differences in tissue destruction still remain to be explained. We hypothesized that local differences in IL–8 could be one of the factors involved in these differences, but we found no association between hogher Il–8 levels and pocket depht. Chung et al.(1997) reported a lower concentration of IL–8 in patients with periodontal disease prior to tratament, but similar total amounts, which accords with our findings. Our results suggest that the amounts of IL–8 in GCF are influenced by the severity gengival inflammation rather than by constitutional differences in the local production that could explain site–specific tissue destruction.</p>
<p>VII – CONCLUSION</p>
<p>The main conclusion of this thesis are: (1) Increased levels of free protease activity are associated with tissue destruction in periodontitis patients, and part of this activity is derived from neutrophil elastase. Free elastase activity is associated with a local impairement in the majo inhibitor of elastase, A1AT. (2) Peripheral neutrophil hyperreactivity in patients having adult periodontitis is also associated with increased release of elastase after Fcy–receptor stimulation. (3) Increase concentration of interleukin–1 is a characteristic trait of a given patiens. (4) The tendency towards higher basal membrane degradation in patients having periodontitis seems to confirm the presence of local hyperactivityof neutrophils. (5) No evidence was found of a correaltion between IL–8 and site–specific differences in tissue destruction.</p>
<p>VII – ACKNOWLEDGEMENTS</p>
<p>IX – REFERENCES</p>
]]></content:encoded>
			<wfw:commentRss>http://www.periodontiamedica.com.br/hyperreactive-neutrophyls-%e2%80%93-a-mechanism-of-tissue-destruction-in-periodontitis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A RELAÇÃO DA ATIVIDADE NEUTROFÍLICA COM A RESPOSTA AO TRATAMENTO PERIODONTAL NÃO -CIRÚRGICO</title>
		<link>http://www.periodontiamedica.com.br/a-relacao-da-atividade-neutrofilica-com-a-resposta-ao-tratamento-periodontal-nao-cirurgico/</link>
		<comments>http://www.periodontiamedica.com.br/a-relacao-da-atividade-neutrofilica-com-a-resposta-ao-tratamento-periodontal-nao-cirurgico/#comments</comments>
		<pubDate>Sun, 14 Mar 2010 23:29:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Teses]]></category>

		<guid isPermaLink="false">http://www.periodontiamedica.com.br/?p=88</guid>
		<description><![CDATA[Alessandra Areas
Faça o Download da tese completa. 
 

]]></description>
			<content:encoded><![CDATA[<p>Alessandra Areas</p>
<p><a href="http://www.periodontiamedica.com.br/wp-content/uploads/2010/03/ATIVIDADE-NEUTROFÍLICA.doc">Faça o Download da tese completa. <br />
 </a></p>
<p><br class="spacer_" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.periodontiamedica.com.br/a-relacao-da-atividade-neutrofilica-com-a-resposta-ao-tratamento-periodontal-nao-cirurgico/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

